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Improving people’s health through research and information
On 20 June the Taoiseach appointed Pat Carey, Fianna Fáil TD 
for Dublin North West, as Minister of State at the Department of 
Community, Rural and Gaeltacht Affairs with special responsibility 
for drugs strategy and community affairs. Mr Carey’s portfolio, 
unlike that of his predecessor Noel Ahern TD, will not include 
responsibility for housing and urban renewal. Mr Carey has served as 
vice-chairman of the Joint Oireachtas Committee on Foreign Affairs 
and as a member of Oireachtas committees on European affairs 
and on EU legislation. He has also chaired the British–Irish Inter-
Parliamentary Body. 
Draft Programme for Government
The draft programme for government agreed by the incoming coalition on 12 June addresses the issues of 
problem alcohol use and illicit drugs under the headings ‘Health’, ‘Local & National Sports Facilities’ and 
‘Justice’.
Drugs: Most of the actions relating to drug use are under the ‘Justice’ heading. The new Government 
will implement the recommendations of the working group on drugs rehabilitation, including providing 
extra detox beds and dedicated community employment places. Two cocaine-specific treatment centres 
will be established and approved pilot cocaine projects will be supported. The Government will support 
the development of projects by local and regional drugs task forces and targeted Garda anti-drug-use 
programmes in schools and third-level institutions, and will continue to use the Young People’s Facilities 
and Services Fund to assist in the development of youth facilities and services in disadvantaged areas. 
Actions aimed at reducing the supply of drugs include increasing Garda powers to allow random searches 
for drugs at particular places, times or events, expanding the Criminal Assets Bureau operational presence 
in each Garda division, and the mandatory registration of mobile phones. Measures to make prisons drug-
free by prohibiting physical contact with prisoners and drug testing on arrival will be introduced. The Drug 
Court programme will be expanded and judges will have the option of sentencing certain offenders to 
mandatory drug treatment programmes in addition to prison terms. 
Under the ‘Local & National Sports Facilities’ heading, the level of ‘own funding’ required from applicants 
to the Sports Capital Programme will be reduced in areas of urban disadvantage, such as RAPID or local 
drugs task force areas.
Alcohol: Under the ‘Health’ heading, the Government commits to implementing the recommendations 
of the working group on alcohol abuse. Actions relating to young people include raising awareness of 
the damage caused by binge drinking, supporting the establishment of alcohol-free youth cafés, and the 
doubling of penalties for all offences relating to providing alcohol to underage persons. Other actions 
include developing a code of practice for off-licences, using the tax system to promote low-alcohol and 
alcohol-free products, and providing early intervention programmes in all social, health and justice services.
Provision is made under the ‘Justice’ heading for an increase in penalties under the Public Order Act, 
especially for alcohol-related disorder. Under ‘Sports Facilities’, the Government will discuss the phasing out 
of sponsorship of sporting events by the alcohol industry.
(Brian Galvin)
The full text of the Draft Programme is on the Fianna Fáil website at www.fiannafail.ie.
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in the next issue of  
Drugnet Ireland.
drugnet 
IRelAND

On 22 March 2007 the National Advisory 
Committee on Drugs (NACD) in Ireland 
and the Drugs and Alcohol Information and 
Research Unit of the Department of Health, 
Social Services and Public Safety in Northern 
Ireland published the fifth and sixth bulletins 
of results from the 2002/2003 all-Ireland 
general population drug prevalence survey.1 
Bulletin 5 focuses on polydrug use in the 
adult population (15–64 years) and Bulletin 6 
focuses on sedative, tranquilliser and anti-
depressant use in the adult population. 
For the purpose of Bulletin 5, polydrug 
use is defined as use of two or more drugs 
in the last month. Polydrug use involves 
the concurrent use of two or more of the 
following substances: alcohol, tobacco, 
any illegal drug or any other legal drugs 
(sedatives, tranquillisers or anti-depressants). 
The findings for Ireland are presented in this 
article. 
Just under one-fifth (19%) of the 4,918 
survey respondents reported that they had 
not used any substance in the last month. 
Among those who had used drugs in the 
last month, the most common substance 
combinations were:
1. 24% had used alcohol and tobacco
2.  1.9% had used alcohol, tobacco and at 
least one illegal drug
3.  1.4% had used alcohol and sedatives, 
tranquillisers or anti-depressants
4.  1% had used alcohol, tobacco and 
sedatives, tranquillisers or anti-depressants
5.  0.6% had used alcohol and at least one 
illegal drug
6.  0.5% had used tobacco and sedatives, 
tranquillisers or anti-depressants
7.  0.2% had used tobacco and at least one 
illegal drug
8.  0.2% had used alcohol, tobacco, at 
least one illegal drug, and sedatives, 
tranquillisers or anti-depressants 
9.  0.1% had used tobacco, at least one illegal 
drug, and sedatives, tranquillisers or anti-
depressants
The combination of alcohol, tobacco and any 
illegal drug was more commonly reported by 
men (2.7%) than by women (2.1%). A higher 
proportion of young adults (15–34 years) 
reported that they had used alcohol with 
tobacco than their older counterparts (35–64 
years), 28% compared to 21%. 
As expected, the results of the polydrug 
use survey reflect drug use in recreational 
situations rather than problematic drug use 
in socially deprived areas or among treated 
problem drug users. 
For the purpose of Bulletin 6, sedatives, 
tranquillisers and anti-depressants were 
grouped as a collective and were not 
presented by their individual drug families. 
The main measures of use were lifetime (ever 
used), use in the last year (recent use) and 
use in the last month (current use).
The key findings were:
One in five (22%) respondents 
reported that they had taken sedatives, 
tranquillisers or anti-depressants during 
their lifetime. Of these, 95% said that the 
drug was prescribed.
Females reported higher prevalence rates 
than males for all three time measures.
The average age for first use of sedatives, 
tranquillisers or anti-depressants was 28 
years for males and 30 years for females. 
The average age of first use by those in 
the 15–34-year age group was 22 years, 
and by those in the 35–64-year age group 
37 years; this may indicate two different 
patterns among the user population.
Ten per cent of respondents had used 
sedatives, tranquillisers or anti-depressants 
in the last month and, of these, 84% had 
taken them on a daily basis.
Sedative, tranquilliser or anti-depressant 
use was more likely among those who 
were aged over 35 years, or long-term 
unemployed, or had left school at primary 
level. 
(Jean Long and Siobhan Reynolds)
1.   National Advisory Committee on Drugs 
and Drug and Alcohol Information and 
Research Unit (2007) Drug use in Ireland 
and Northern Ireland. 2002/2003 drug 
prevalence survey: polydrug use results. 
Bulletin 5; and Drug use in Ireland and 
Northern Ireland. 2002/2003 drug 
prevalence survey: sedatives, tranquillisers 
or anti-depressants. Bulletin 6. Dublin: 
National Advisory Committee on Drugs.
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Between 12 and 16 March 2007 the Commission on 
Narcotic Drugs (CND), the central UN policy-making body 
dealing with drug-related matters, met for its 50th session 
in Vienna.1 The session was attended by representatives of 
47 states that are members of the Commission, observers 
for other UN member states and non-member states, 
representatives of organisations of the UN system, and 
observers for inter-governmental, non-governmental and 
other organisations. There were 81 registered civil society 
delegates and more NGO representatives included in 
government delegations.2
Prior to the meeting, both the United Nations Office for 
Drugs and Crime (UNODC),3 mandated to assist member 
states in their fight against drugs, crime and terrorism, 
and the International Narcotics Control Board (INCB),4 
the independent and quasi-judicial monitoring body for 
the implementation of the UN international drug control 
conventions, published their annual reports, and these 
formed the basis for much of the debate over the five days. 
In his opening address, Antonio Maria Costa, executive 
director of UNODC, reaffirmed his assertion at the 49th 
session that global controls had stabilised the supply of illicit 
drugs, as well as the demand. He observed that specific 
problems, some very serious, still persisted, and that ‘for 
even greater improvements we need stronger social vaccines 
to protect society against drugs’. 
The agenda for the CND session included a thematic debate 
on the control of precursor chemicals, including those 
needed for the illicit manufacture of methamphetamine, 
amphetamine, ‘ecstasy’, heroin and cocaine. Drug 
demand reduction, illicit drug traffic and supply, and the 
implementation of the international drug control treaties 
were also discussed. Finally, there was a discussion on the 
progress made by governments in meeting the goals and 
targets set for the years 2003 and 2008 at the twentieth 
special session of the General Assembly (UNGASS), held in 
New York in 1998. 
Looking forward to the CND session for 2008, member 
states agreed that UNODC will present an assessment report 
on achievements in respect of the 1998 UNGASS targets, 
and that the thematic debate will focus on ‘underscoring 
the value of objective, scientific, balanced and transparent 
assessment’.5 After the 2008 session, there will be a year for 
reflection, concluding with a major focus (and decisions) on 
the way forward at the 2009 CND session. 
The 2008/9 period is also seen as an opportunity for the 
NGO community to reflect on its achievements in drug 
control, exchange ideas on approaches, reach agreements 
on ways to work together, and make recommendations 
to multilateral agencies and UN member states on future 
directions for drug control. To this end the Vienna NGO 
Committee on Narcotic Drugs (VNGOC),6 working with 
the CND and UNODC, is hosting a 4th International NGO 
Forum to contribute to the 1998–2008 review and the 
forward-looking, agenda-setting exercise. The Forum will 
focus on three topics:
1.  Highlighting tangible NGO achievements in the field of 
drug control, with particular emphasis on contributions 
to the 1998 UNGASS Action Plan such as achievement in 
policy, community engagement, prevention, treatment, 
rehabilitation and social-reintegration 
2.  Reviewing best practices related to collaboration 
mechanisms among NGOs, governments and UN 
agencies in various fields of endeavour and proposing new 
and/or improved ways of working with the UNODC and 
CND. 
3.  Adopting a series of high-order principles, drawn from 
the Conventions and their commentaries, that would be 
tabled with the UNODC and CND for their consideration 
and serve as a guide for future deliberations on drug 
policy matters.
In the run-up to the Forum, NGOs involved in drug control 
around the world are invited to complete a questionnaire 
as a means of collecting information towards the goals 
identified in the 1998 UNGASS Action Plan.  A series of 
semi-structured interviews is also being conducted with 
key NGO informants to obtain more detailed insights on 
gaps and ideas for future direction.  The Conventions, 
their commentaries and other relevant documents will 
be reviewed to identify a series of guiding principles for 
consideration and discussion by Forum participants.  
In addition, there will be a review of other NGO/UN 
consultation mechanisms with a view to recommending 
a new more systematic and substantive process for NGO 
contributions to CND and UNODC. Finally, a complete 
report will be prepared for tabling with CND, UNODC and 
other appropriate actors. 
(Brigid Pike)
1.  The official documents produced for the CND 50th Session 
are available on the CND page of the UNODC website at 
www.unodc.org 
2.  For an account of the CND 50th Session from an NGO 
perspective, see International Drug Policy Consortium (2007) 
The 2007 Commission on Narcotic Drugs. IDPC Briefing Paper 5. 
Available at www.idpc.info 
3.  UNODC (2007) United Nations Office on Drugs and Crime 
Annual Report 2006. Available at www.unodc.org 
4.  INCB (2007) Report of the International Narcotics Control Board 
for 2006. Available at www.incb.org 
5.  E/CN.7/2007/L.14/Rev.1, Measures to meet the goal of 
establishing by 2009 the progress achieved in implementing 
the declarations and measures adopted by the General 
Assembly at its twentieth special session. Vienna, 15 March 
2007.
6.  Established in 1983, the objective of the Vienna NGO 
Committee on Narcotic Drugs (VNGOC) is to support the 
work of the UNODC, provide information on NGO activities 
and involve a wide sector of civil society in raising awareness 
of global drug policies.  Further information on the Forum, 
and the NGO questionnaire on UNGASS 2008 goals, may be 
found on the website of the VNGOC at www.vngoc.org
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Between 22 and 23 March 2007, 49 drug policy researchers 
from around the world met in Oslo for the inaugural 
meeting of the International Society for the Study of Drug 
Policy (ISSDP).1 Conference participants heard some 30 
papers, organised around the following themes.
1. Developing harm indexes for policy decisions
There is increasing interest in developing summary 
measures that express the severity of drug problems. For 
example, the UK Home Office has published an index for 
measuring outcomes of drug policy decisions.2 Sandeep 
Chawla of the United Nations Organization on Drugs 
and Crime (UNODC) presented a paper on constructing 
policy-relevant harm indexes.3 A number of other papers 
addressed various aspects of drug-related harm, including 
the specific nature of supply-side and demand-side harms 
and the evaluation of harm-reduction interventions.
2.  Estimating government expenditures on drug policy 
As governments spend an increasing amount of money on 
the effort to reduce drug use and related problems, there 
has been increased interest in developing effective ways 
of measuring the scale and composition of drug policy.4 
Speakers at the conference on budgets and costs included 
Luis Prieto of the European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA). 
3.  Modelling the effects of specific policies and 
programmes
There have been substantial advances in dynamic systems 
approaches, complex systems science and systems thinking 
in recent years. The application of these approaches to 
drug policy has the potential to allow close examination 
of the dynamic interactions between interventions, of the 
trajectories of drug use and harm, and of models within 
the policy-making process. A number of participants in 
the Australian Drug Policy Modelling Program (DPMP) 
presented papers on their work developing the evidence 
base for policy, developing, implementing and evaluating 
dynamic policy-relevant models of drug issues, and studying 
policy-making processes.5
4.  Assessing the impact of harm reduction and 
substitution treatment initiatives
Harm-reduction practices are not necessarily directed only 
towards reducing drug-related harm to the individual; 
they are motivated also by public health and public safety 
concerns. The overall impact of harm reduction and 
substitution treatment on the epidemiological situation as 
well as on the drug market has less often been the object 
of research. Among contributors on this theme was Mary 
O’Shea of Merchants Quay Ireland, who presented a paper 
on the politics of safer injecting facilities in Ireland.6 
Drugs and public policy
In addition to the contributions on the four themes above, 
several papers addressed aspects of the policy-making 
process, including the philosophical underpinnings of drug 
policy, bridging the gap between researchers and policy 
makers, and the dynamics of drug policy and drug research. 
The conference heard the first public report on the Drugs 
and Public Policy Project (DPPP). The DPPP was initiated in 
November 2004 as a collaborative effort by an international 
group of addiction scientists to improve the linkages 
between addiction science and drug policy. Seed funding 
was provided by the Society for the Study of Addiction 
(SSA). Current collaborators include Griffith Edwards, John 
Strang and David Foxcroft of the UK; Peter Reuter, Jonathan 
Caulkins and Keith Humphreys of the USA; Isidore Obot 
(Nigeria and WHO); Maria Elena Medina Mora (Mexico); 
Ingeborg Rossow (Norway); Jurgen Rehm (Canada); and 
Robin Room (Australia). It is intended to produce a book, 
modelled on Alcohol: no ordinary commodity,7 which was 
sponsored by the World Health Organization and the SSA. 
The new book will include epidemiological data on the 
global dimensions of drug misuse, as well as a critical review 
of the scientific evidence relating to drug policy at the local, 
national and international levels. 
International Society for the Study of Drug Policy 
(ISSDP)
The ISSDP was formally constituted by the participants at 
the conference. A Board was elected, with Professor Peter 
Reuter, USA, as president, and Associate Professor Alison 
Ritter, Australia, as vice-president. It is planned to hold the 
second annual conference of the ISSDP in Lisbon in April 
2008. 
(Brigid Pike)
1.  For further information on the ISSDP and the conference, 
visit www.issdp.org 
2.  MacDonald Z, Tinsley L, Collingwood J, Jamieson P and 
Pudney S (2005) Measuring the harm from illegal drugs 
using the Drug Harm Index. Home Office Online Report 
24/05. Available at www.homeoffice.gov.uk/rds/pdfs05/
rdsolr2405.pdf
3.  In its 2005 World Drug Report, UNODC presented an 
index at the national level that attempted to capture 
differences in the sum of consumption, trafficking  
and production problems. The report is available at  
www.unodc.org/pdf/WDR_2005/volume_1_web.pdf
4.  See, for example, papers from a symposium ‘What drug 
policies cost’, published in the journal Addiction (101) in 
2006. 
5.  For further information on the Drug Policy Modelling 
Program, visit www.dpmp.unsw.edu.au 
6.  A version of this paper may be found at M O’Shea (2007) 
‘Introducing safer injecting facilities (SIFs) in the Republic 
of Ireland: “Chipping away” at policy change’. Drugs: 
education, prevention and policy. 14/1: 75–88.
7.  Babor T, Caetano R, Casswell S, Edwards G, Giesbrecht 
N, Graham K et al. (2003) Alcohol: no ordinary commodity. 
Research and public policy. Oxford: Oxford University 
Press.
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Approved in February 2007 by Mary Harney TD, Minister for 
Health and Children, the National Service Plan 2007 (NSP) 
of the Health Service Executive (HSE) outlines the HSE’s 
plans in the drugs area during 2007.1 It states that work 
will begin on scoping the transition of the management 
of alcohol services from mental health to social inclusion 
services, and that a review of how drug and alcohol services 
can have a better fit with the unitary structure of the HSE 
will be completed.
The HSE’s drug-related services are provided primarily 
through Social Inclusion Services, which is part of the 
Primary, Community and Continuing Care (PCCC) 
directorate of the HSE. Table 1 (see p.6) summarises the 
HSE’s Social Inclusion outputs in respect of drugs and HIV 
services for 2006 and the deliverables against which the HSE 
will be assessing its performance in 2007. 
Table 2 (see p.7) outlines how the €6 million allocated in 
the government’s 2007 budget to implement the HSE-
related elements of the National Drugs Strategy will be 
spent. 
The NSP also records that during 2007 the Population 
Health Directorate of the HSE will complete further iterations 
of the SLAN (Survey of Lifestyle, Attitudes and Nutrition) 
and ESPAD (European School Survey Project on Alcohol and 
Drugs), continue to work on health promotion campaigns 
in relation to, among other things, alcohol and tobacco, and 
continue to implement the Action Plan on Alcohol. 
(Brigid Pike)
1.  Health Service Executive (2007) National Service Plan 
2007. Available at www.hse.ie 
HSE outlines plans for drug-related 
services in 007
RADE (recovery through art, drama and education) was 
established in August 2004 as an innovative programme 
for recovering drug users. Its purpose is to help participants 
‘find a path forward into personal development and 
education through participation in the arts’.1 At present, 
there are 21 participants involved in the arts training 
programmes which are conducted in collaboration with 
some of Ireland’s leading contemporary artists across all art 
forms. 
President Mary McAleese opened RADE’s 2007 Showcase 
in the Project Arts Centre in Temple Bar in April. The 
president was introduced by poet Theo Dorgan, who 
was MC for the evening. The event opened with poetry 
readings from Mick (Elegy for Uncle Christy) and Joanne 
(Nobody knows what it’s like). This was followed by a 
short documentary film, a Tai Chi display and a drama 
performance by the participants.
President McAleese set the activities and challenges faced 
by the participants in RADE in the context of the harms 
associated with problematic drug use: ‘Civic society is 
generally impatient with addicts, frustrated at the waste of 
life, angry at the damage inflicted on the self and others. 
Families, friends and partners often reach exhaustion 
point too, so it is all the more important that there is an 
organisation like RADE that doesn’t walk away defeated 
or overwhelmed by the enormity of the job.’ 2 Directing 
her comments at the participants throughout her address, 
she commended them for their courage in taking on their 
addiction: ‘It takes guts to take on the monster within 
that is addiction, and the works showcased here speak 
movingly of the courage and the commitment it has 
taken each artist to get here. When they took the first 
steps towards this day they were in an altogether different 
place – they were in many ways different people. Today 
they are stronger and wiser. They are men and women of 
achievement, people of substance not substance abusers.’
RADE has three primary objectives:
to get Dublin City Council to develop RADE’s current 
‘dilapidated’ premises in New Street, Dublin 8, 
as a state-of-the-art centre, or to provide suitable 
alternative premises;
to develop and expand its drama and film 
programmes;
to increase the reach of its programmes into the 
community and to involve influential community 
forces, such as parents, more directly in its work.
(Johnny Connolly)
1.  RADE (recovery through art and education) (2007) 
Somewhere to flap your wings – Inside RADE 2006–2007. 
Dublin: RADE.
2.  The full text of President McAleese’s remarks at the 
RADE Showcase is available in the Speeches section of 
the website www.president.ie
■
■
■
President opens RADE’s cultural 
showcase 
President Mary McAleese with some of the participants 
in the RADE 2007 Showcase at the Project Arts Centre in 
Dublin (Photo: Bryan O’Brien, Irish Times)
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HSE National Service Plan (continued)
Table 1  Drugs and HIV services – outputs and deliverables for 007 (after HSE NSP 2007: 8–9)
Focus Output 2006 Deliverable 2007
Expand the Tier 3 teams. Additional funding was provided for Specialist 
Adolescent Addiction Teams.
Continued provision of existing 
levels of service
Enhance treatment services with 
a particular focus on under-18s.
New protocols and a policy on treatment of 
under-18s were disseminated and promoted 
nationally. National Training Workshops were 
provided for frontline staff on the treatment of 
under-18s with serious drug problems.
Substance misusers to have immediate access 
to professional assessment, and treatment as 
deemed appropriate not later than one month 
after assessment. The extent of substance misuse 
in the under-18-year group needs monitoring.
Indicator (AD3, AD4):
Percentage of adults (new clients) 
commencing treatment within one month 
– 60% (heroin) 95% (all other substances).
Percentage of under-18s (new clients) 
commencing treatment within one month 
– 65% approx.
■
■
Increase the provision of 
training to staff on appropriate 
interventions for under-18s.
Implement the protocols and the 
new policy nationally in line with 
available resources.
Work towards improved 
performance in these areas.
Enhance treatment services to 
cocaine and polydrug users.
Information on the trends and prevalence of 
cocaine use was disseminated.
A workshop was provided on appropriate 
treatment interventions to address cocaine use.
Develop a model for the 
management of cocaine abuse 
and deliver appropriate training to 
HSE staff.
Combat substance misuse 
through a concerted focus on 
supply reduction, prevention, 
treatment and research.
Develop a comprehensive 
action plan for the delivery of 
rehabilitation services in line 
with the National Drug Strategy 
review and the outcome of the 
Rehabilitation Working Group.
Monitor the prescribing of 
benzodiazepines.
Focus on reducing alcohol-
related harm, including 
implementation of the
recommendations of the 
Working Group on Alcohol and 
taking account of the
recommendations of the 
Strategic Task Force on Alcohol.
Work on the Alcohol Aware pilot with the 
Irish College of General Practitioners (ICGP) 
commenced in 2006.
Implement relevant 
recommendations from the
Strategic Task Force on Alcohol, 
within available resources.
Work with Emergency Department 
(ED) and Primary Care Services on 
the early detection and screening 
of people with problematic and 
dependent alcohol use.
Complete review of current 
mental-health-based alcohol 
services with a view to improved 
integration.
Number of clients in methadone 
treatment
Average of 6,800 per month 6,800 (average per month)
Number of methadone 
treatment places used during 
the period
Average of 6,800 per month 6,800 (average per month)
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HSE National Service Plan (continued)
Table   Investment funding in Social Inclusion services for 007 to implement health-
related aspects of the National Drugs Strategy (after HSE NSP 2007: 10–10)
Focus Funding Human resource
implications 
estimated
Deliverable 07
Addressing health-related aspects 
of the National Drugs Strategy 
through:
€6m (B)
Continued implementation of the 
report on treatment services for 
under-18s presenting with serious 
drug problems,
including the enhancement of 
consultant-led multidisciplinary 
teams
50 Completion of teams in 
Dublin North East
Enhancement of teams in 
Dublin-Mid Leinster
Establishment of team in 
HSE South (Cork)
Establishment of team in 
HSE West (Limerick)
Expansion of harm reduction 
services, including needle 
exchange, to counter the incidence 
of HIV and hepatitis C among 
intravenous drug users
Continuation and 
expansion of programme 
that commenced in 2006.
Reorientation and expansion 
of treatment services and the 
upskilling of HSE staff to address 
changing patterns of polydrug use
4 Cocaine and polydrug use 
programme established, 
national coordinator in 
place.
Two pilot sites identified 
and established.
Detox facilities programme 2 Support for the 
establishment of residential 
detox programmes 
throughout the country. 
Initial places and sites 
identified in 2007.
A specific initiative for homeless 
persons 
10 Employment of eight 
counsellors to support 
addiction services targeted 
at homeless communities 
throughout the country.
In March 2007, a Eurobarometer special report, 
Attitudes towards alcohol,1 was published. 
Commissioned by the Health and Consumer Protection 
Directorate-General of the European Commission, 
the main aim of this survey was to obtain a picture of 
European citizens’ drinking habits and their attitudes 
towards measures that potentially influence alcohol-
related harm. The study sample comprised over 
28,000 participants from 29 European countries, 
including Ireland. Interviews were conducted face-to-
face in people’s homes and took place in October and 
November 2006. 
The majority of Europeans drink, with 66% stating 
that they had consumed an alcoholic beverage in 
the preceding 30 days. The corresponding figure for 
Irish respondents was 70%, representing an increase 
of 10 percentage points since the Eurobarometer 
survey conducted in 2003. Irish people drink on fewer 
occasions than their European counterparts. Just 2% 
consume alcohol daily, compared to 13% of Europeans, 
while 41% stated that they drink once per week. 
Although Irish people drink on fewer occasions, 
they reported a higher prevalence of heavy episodic 
drinking. The majority of the EU population reported 
having fewer than two drinks on a typical drinking 
occasion (70%), while just 10% usually consume five 
or more drinks in one sitting. Ireland tops the country 
scale for heavy drinking by a considerable margin, 
with just 28% consuming fewer than two drinks per 
drinking occasion and 34% usually consuming at 
least five drinks. Furthermore, when asked about the 
frequency of consuming five or more drinks on one 
occasion in the past year, 28% of Europeans stated 
they did so at least once a week, compared to 54% 
of Irish respondents, which was the highest recorded 
value. The survey also found men more likely to engage 
in binge drinking than women and, while younger 
people (aged 15–24) and students claim to drink on 
fewer occasions per month than the EU average, they 
are more inclined to binge drink than the average 
European.
The survey also investigated opinions regarding the 
responsibility for and prevention of alcohol-related 
harm. At a European level, a slight majority (52%) 
consider individuals to be mainly responsible for 
protecting themselves from alcohol-related harm, 
although a significant proportion (44%) think that 
public authorities have to intervene in order to protect 
individuals. 
Over two-thirds of the EU population (68%) believe 
that higher prices for alcohol would not discourage 
young people and heavy drinkers from consumption, 
and just 33% stated that they would buy less alcohol if 
prices were to increase by 25%. Fifteen per cent believe 
they would buy more alcohol if prices decreased by 
25%. Younger respondents appear to be more sensitive 
to price changes, with 44% stating that they would buy 
less alcohol if prices increased and 26% claiming they 
would buy more alcohol if prices decreased. 
There is broad support for putting warning labels on 
alcohol bottles in order to inform pregnant women 
and drivers of the dangers associated with drinking 
alcohol. Three-quarters of Europeans (77%) are in 
favour of such an initiative, while 82% of Irish people 
are supportive of warning labels. There is also strong 
support for measures that restrict young peoples’ 
exposure to alcohol, with 76% approving of the 
banning of alcohol advertising that targets young 
people. All European countries are strongly in favour 
of prohibiting the selling and serving of alcohol to 
people under the age of 18. Eighty-seven per cent 
of Europeans and a similar proportion of Irish people 
(89%) favour such restrictions. Not surprisingly perhaps, 
a lower proportion of the youngest respondents (74%) 
favour controls that tighten regulations concerning 
themselves. 
The survey also included questions pertaining to alcohol 
consumption and driving. It is recommended that the 
standard blood alcohol concentration (BAC) permitted 
for drivers should not exceed 0.5 g/l. All European 
countries, with the exception of Ireland, the UK and 
Malta (all three of which have a permitted BAC level 
of 0.8 g/l), have adopted this limit. Many respondents 
are not well-informed about the permitted BAC in their 
country, with Irish respondents extremely uninformed 
about the allowed BAC while driving. When given 
a choice of four answers, not a single respondent 
correctly identified the Irish BAC level as being in the 
range 0.60–1 g/l. This is surprising especially when 
one considers that this survey was conducted at a time 
when there was a lot of media attention in Ireland 
regarding the introduction of random breath testing. 
There is widespread support for reducing the permitted 
BAC for young and novice drivers to 0.2 g/l in all EU 
member states. Seventy-three per cent of all Europeans 
and 74% of Irish people favour this change. Eighty per 
cent of EU citizens believe that random police alcohol 
checks would reduce alcohol consumption prior to 
driving. Irish people demonstrated the second-highest 
level of support for this proposal (91%). 
In conclusion, this survey shows an increase in the 
number of people drinking compared to 2003, but 
the frequency and the amount of consumption has 
somewhat decreased. However, this observation does 
not appear to apply to Ireland, which recorded the 
highest levels and frequency of binge drinking in the EU. 
There is also widespread support for measures aimed at 
protecting young people from premature exposure to 
alcohol and reducing alcohol-related road accidents. 
(Deirdre Mongan)
1.  TNS Opinion & Social (2007) Attitudes towards 
alcohol. Special Eurobarometer 272. Brussels: 
European Commission.
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A public seminar, ‘Alcohol: Is our love affair with 
alcohol causing more pleasure or pain?’, was held 
by the Faculty of Public Health Medicine at the Royal 
College of Physicians of Ireland (RCPI) on 19 April 
2007. 
Dr Jim Kiely, chief medical officer with the 
Department of Health and Children, stated that the 
recommendations of the Strategic Task Force on 
Alcohol had not been introduced in spite of public 
support for changes in alcohol policy.
Marion Rackard, executive director of Alcohol Action 
Ireland, said there is not equal access to treatment 
services around the country for people with alcohol 
problems or their families. She said that alcohol was 
too easily available and too cheap, and there was too 
much tolerance for drunkenness. She highlighted the 
need for a National Alcohol Strategy and the political 
will to tackle the problem of alcohol misuse in Ireland.
Dr Declan Bedford of the Faculty of Public Health 
Medicine at RCPI spoke of the connection between 
suicide and alcohol consumption and said that 
90% of suicides among under-30s were found to 
have alcohol in their blood and 58% had double 
the legal driving limit. In addition, 38% of road 
fatalities were alcohol related and every eighth new 
patient attending Accident and Emergency was there 
because of an alcohol-related injury. He also said that 
the recommendations of the task force needed to 
be implemented urgently and supported measures 
to increase alcohol taxation, decrease availability 
and reduce the exposure of children to advertising, 
sponsorship and promotions. However, he stressed 
that strong local and political leadership was 
necessary to achieve this. 
(Deirdre Mongan)
Our love affair with alcohol
In January 2007, the Geary Institute in University 
College Dublin (UCD) published preliminary results 
from its college study Behavioural economics and 
drinking behaviour.1 The main aim of this study was to 
examine alcohol consumption in an Irish university, in 
particular the role of demographic factors, personality, 
age of drinking onset and peer drinking. 
All the students in an Irish university were contacted 
via email and asked to participate in a web-
based survey. In total, 4,500 students responded, 
representing approximately 20% of the student body. 
Information collected included personal details such 
as gender and age, physical health and psychological 
well-being, alcohol consumption patterns, personality, 
risk perception, time management and family 
background. Drinking behaviour was assessed 
by examining monthly alcohol expenditure and 
administering the AUDIT (alcohol use disorders 
identification test) screening examination. Single-
equation regression models were used to study the 
determinants of alcohol consumption patterns and 
AUDIT scores. 
The study found that whether a student drank or 
abstained was determined by a number of variables. 
When other factors were controlled for, it was found 
that females in general and students from families 
with a high parental income were more likely to 
drink. There was little evidence that parental drinking 
influenced students’ decisions to consume alcohol. 
Drinking was related to closest-peer and outside-
college-peer drinking, though not to college-friend 
drinking.
When the determinants of AUDIT scores were 
examined, the results revealed a substantial effect of 
peer-group drinking but very little effect of parental 
drinking. AUDIT scores were higher for those who 
began drinking at an earlier age. Both cannabis and 
ecstasy usage were associated with higher AUDIT 
scores, suggesting complementarities between 
alcohol consumption and illicit drug use. Males scored 
substantially higher than females on the AUDIT, even 
after controlling for other factors. Associated with 
lower AUDIT scores were high perception of risks 
related to drinking and conscientiousness in terms of 
personality. 
The determinants of alcohol expenditure were also 
studied and it was found that alcohol expenditure 
and alcohol consumption were not strongly related. 
While disposable income had an effect on alcohol 
expenditure, it did not have an effect on the AUDIT 
score. This suggests that higher income students, 
rather than consuming more alcohol, tended to 
consume more expensive alcohol. 
The authors concluded that income was a very weak 
explanatory factor for alcohol consumption, and that 
consumption was better explained by personality 
and peer factors than by parental resources, family 
background or disposable income. They also 
suggested that the interplay between parental, 
peer and sibling drinking and their effect on alcohol 
consumption should remain a high priority for future 
research. 
(Deirdre Mongan)
1.  Delaney L, Harmon C and Wall P (2007) 
Behavioural economics and drinking behaviour: 
preliminary results from an Irish college study. Dublin: 
UCD Geary Institute.
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The Criminal Justice Act 2007 was published by the 
Government on 15 March of this year, passed by the 
Oireachtas (Parliament) on 24 April, and signed into law 
by the President on 10 May. 
The Act contains a number of important changes to 
the criminal justice system, including increased Garda 
detention powers, changes to existing provisions in 
relation to the right to silence and the introduction of 
mandatory sentencing for a range of offences. Many of 
these changes have been introduced in the context of 
growing concern about drug-related crime.
Currently, seven-day detention powers are available to 
the Garda Síochána (the Irish police) under the Criminal 
Justice (Drug Trafficking) Act 1996. Part 9 of the Criminal 
Justice Act 2007 extends the scope of these powers to, 
among other offences, murder involving the use of a 
firearm or explosive and murder of a Garda member or 
prison officer in the course of their duty. 
The Act amends existing provisions relating to the right to 
silence by clarifying the circumstances in which inferences 
may be drawn from the refusal of an accused person to 
answer certain Garda questions. Such inferences can then 
be used as evidence against that person during court 
proceedings. Part 4 of the Act allows for inferences to 
be drawn when an individual fails or refuses to account 
for objects, substances or marks on their person and 
where the Garda member reasonably believes that such 
matters may be linked to the commission of an offence. 
However, the Act provides for certain safeguards for the 
accused. For example, the accused will not be convicted 
of an offence solely or mainly on such inferences and the 
section shall not apply unless the interview is recorded by 
electronic or similar means. 
Part 3 of the Act contains proposals for mandatory 
sentencing for offences linked to organised crime, 
including firearms and drug trafficking offences. Under 
these proposals the court must impose a sentence that 
is at least three-quarters of the maximum sentence 
permissible under the law for that offence. If the 
maximum term is life imprisonment, the court shall 
specify a term of imprisonment of not less than 10 years.
Part 5 of the Act proposes amendments to the Misuse 
of Drugs Act 1977, specifically in relation to the area of 
sentencing of those in possession of drugs with intent to 
supply. The key provisions contained in this section of the 
Act include the following:
The minimum period of imprisonment for those 
convicted under Section 15A or 15B of the Misuse 
of Drugs Act 19771 is to be 10 years, aside from 
some exceptional circumstances whereby the court 
determines that it would be unjust to impose such 
a sentence.2
The minimum period of imprisonment for those 
convicted of a second or subsequent offence under 
Section 15A or 15B of the Misuse of Drugs Act 
1977 is to be 10 years.
The main purpose of these provisions is to ensure that 
mandatory sentencing for supplying drugs should be 
■
■
imposed in all but the most exceptional circumstances.
The Irish Human Rights Commission (IHRC)3 and the 
Irish Council for Civil Liberties (ICCL)4 have expressed 
concerns about a number of provisions in the new Act. 
The IHRC refers to seven-day detention as ‘a serious 
curtailment of a persons right to personal liberty…that 
warrants real cause and justification’ (p. 3). This view 
is echoed by the ICCL, which questions the merit of 
extending such powers to a further range of offences 
when the current provisions under the Criminal Justice 
(Drug Trafficking) Act 1996 are, according to the ICCL, 
‘rarely, if ever used’ (p. 6). Furthermore, the IHRC 
contends that the introduction of this measure may result 
in Ireland violating its obligations under the European 
Convention on Human Rights and the International 
Covenant on Civil and Political Rights.
Both the IHRC and ICCL have expressed concerns over 
the changes in sentencing practice introduced by the Act. 
The ICCL maintains that these new rules on mandatory 
sentencing may ‘impinge upon the constitutional duty of 
judges to ensure that sentences are proportionate to both 
the gravity of the crime and the personal circumstances of 
the offender’ (p. 8). This view is supported by the IHRC, 
which states that provisions which impose on the judiciary 
an obligation to sentence an offender to a specific term of 
imprisonment raise ‘fundamental concerns’ in relation to 
the separation of powers doctrine and judicial discretion 
in relation to sentencing (p. 4).
Both the ICCL and the IHRC, together with leading 
barristers5 and the Law Society,6 have expressed disquiet 
in relation to the timeframe in which the measures were 
enacted. The Law Society has called for greater debate 
about the provisions of the legislation. 
(Johnny Connolly and Angela Morgan)
1.  These sections relate specifically to possession of drugs 
with intent to supply.
2.  For example, cases in which the convicted person 
pleaded guilty to the offence or provided assistance 
in the investigation of the offence. The Bill also states 
that if a person convicted of an offence under section 
15A or 15B of the Misuse of Drugs Act was addicted 
to one or more controlled drugs at the time of the 
offence and if this was deemed to be a key factor in 
the commission of the offence, then the sentence can 
be reviewed after five years.
3.  Irish Human Rights Commission (2007) Observations 
on the Criminal Justice Bill 2007. Dublin: Irish Human 
Rights Commission. www.ihrc.ie/press_releases
4.  Irish Council for Civil Liberties (2007) What’s wrong 
with the Criminal Justice Bill 2007? Dublin: Irish Council 
for Civil Liberties. www.iccl.ie
5. Letter to the Irish Times of 21 February 2007.
6.  Law Society of Ireland (2007) ‘Law Society’s deep 
concern at Government’s intention to rush through 
far-reaching changes in criminal law’. Press release 27 
February 2007. Retrieved 04 May 2007 from www.
lawsociety.ie/displayCDAContent.aspx?groupID=149&
HeaderID=7024&code=latest_news
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In March 2007 Minister Noel Ahern TD launched 
Research leading to a future strategy for Dublin 
North East Drugs Task Force.1 The document 
reports that a growing range of drugs is being 
used in the task force area, that polydrug use 
has become increasingly common, and that, 
in contrast to heroin use, there is no apparent 
association between cocaine or cannabis use and 
socio-economic background. 
The definition of prevention is to be widened to 
include individual, community and family ‘risk’ as 
well as ‘protective’ factors. Formal and informal 
prevention methods are to be used, and channels 
are to include schools, the media, outreach, and 
initiatives in respect of active citizenship and 
‘social capital’. 
The provision of treatment and rehabilitation 
options will follow a polydrug use and continuum 
of care approach, and alternative project 
approaches will be offered, to cater not only for 
opiate users but also for polydrug and alcohol 
users, who may be less likely to seek assistance 
through existing projects. The task force will 
explore the establishment of a community-based 
project integrating medical and social treatment 
options. The quality of services will be improved 
through training and development for service 
deliverers, and the establishment of a users’ 
forum. 
Supply and control initiatives will include 
building a better relationship between police 
and the community; the development of a toxic 
substances protocol; setting up an information 
line for passing on information to the gardaí; and 
support for social planning in new and existing 
areas, to help reduce the incidence of drug 
dealing and anti-social behaviour.
Targeting of services is also highlighted. 
Prevention, diversionary and treatment services 
are to be developed specifically for young 
people. Families will be the subject of targeted 
interventions in the areas of prevention, harm 
reduction, treatment and ultimately rehabilitation 
and social reintegration. Special and focused 
initiatives for cocaine users are to be explored. 
Stakeholders interviewed for the strategy were 
generally of the view that in recent years the 
task force has ‘lost some direction, vibrancy and 
relevance to current drug problems’ (p. 56). The 
report recommends a raft of structural changes to 
revitalise the task force, including focusing the role 
of the task force more narrowly on developing 
overall policy, developing a thematic annual work 
plan, overseeing the implementation of strategy 
and governance; strengthening the expert or 
advisory roles of the task force’s sub-committees; 
setting up local area committees to develop local 
actions and measures linking in with new and 
existing local projects; building a community 
representative structure to ensure the community 
remains at the heart of the task force while also 
strengthening accountability; and establishing a 
technical support unit to assist the funded projects 
and services in accessing the latest research, 
information and best practice.
Finally, acknowledging that the solution to the 
drugs problem is bigger than the task force, the 
strategy identifies a series of initiatives to develop 
integrated/joined up/interagency responses, to 
investigate the relationship of drug problems to 
social exclusion and the local economy, and to 
undertake advocacy, lobbying and networking.
Not considered in Research leading to a future 
strategy are the efficiency, effectiveness, potential 
impact and value for money of the options 
identified in the report. These matters were the 
focus of an expenditure review of local drugs 
task forces completed in October 2006.2 Among 
its findings and recommendations are several 
relevant to task forces reviewing their strategies. 
For example: 
Consideration of the likely impact and value 
for money of projects should inform the 
selection and overall mix of projects. 
To enhance efficiency, the review recommends 
the establishment of clear reporting 
relationships and related monitoring systems, 
the development of standard monitoring 
templates for projects, and the adoption of a 
system of performance indicators for projects, 
LDTF processes, individual LDTFs, and the 
LDTF Programme as a whole.
While considering the LDTF model effective, 
the review raises a concern regarding the 
feasibility of the model: ‘…there is a widely 
held view that the energy and capability of the 
community to engage in drug interventions is 
subject to limits. This indicates that relatively 
realistic targets for the LDTF Programme 
should be set going forward’ (p. 47). 
(Brigid Pike)
1.   Watters N (2007) Research leading to a future 
strategy for Dublin North East Drugs Task Force. 
Dublin: Dublin North East Drugs Task Force. 
Available online at www.dnedrugstaskforce.ie 
2.   Goodbody Economic Consultants (2006) 
Expenditure review of the local drugs task 
forces. Commissioned by the Department 
of Community, Rural and Gaeltacht Affairs. 
Available online at www.pobail.ie
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The National Advisory Committee on Drugs 
(NACD) launched the report An overview of cocaine 
use in Ireland: II 1 on 8 March 2007. Prepared jointly 
by the NACD and the National Drugs Strategy 
Team (NDST), the report looks at the prevalence, 
prevention and treatment, and consequences of 
cocaine use in Ireland. 
This report updates the baseline information 
presented in the NACD’s 2003 cocaine report.2 Dr 
Des Corrigan, chairman of the NACD, stated at the 
launch that all indicators show a continued increase 
in cocaine use that crosses all social strata.
Examining data from the NACD/DAIRU (Drug and 
Alcohol Information and Research Unit, Northern 
Ireland) Drug Prevalence Survey 2002/2003,3 the 
authors conclude that cocaine use is highest among 
the 15–34 age group, is predominantly an urban 
phenomenon and is more common among males 
than females. The last point is consistent with 
findings from the College Lifestyle and Attitudinal 
National (CLAN) survey in 2005.4
Comparisons between data collected in the 1998 
and the 2002 National Health and Lifestyle Surveys 
(SLAN)5 indicate that cocaine use has increased. In 
1998 1.8% of males and 0.6% of females surveyed 
had used cocaine in the last year. In the 2002 
survey, levels of cocaine use in the last year had 
increased to 3% among males and 1.9% among 
females. Data from the Human Toxicology Section 
of the State Laboratory, which carries out analysis 
for coroners and criminal cases, and the Medical 
Bureau of Road Safety, based on road safety tests, 
indicate an increase in cocaine-positive tests 
between 2002 and 2005.
Using Garda data on offences under the Misuse of 
Drugs Act 1977, the report reveals an increase in 
the number of cocaine-related offences from 180 in 
2000 to 1,224 in 2005. Forty-seven per cent of the 
cocaine-related offences recorded in 2005 were in 
the Dublin Metropolitan Region. The report shows 
that both Garda and Customs seizure data indicate 
a growing supply of cocaine in Ireland. In 2005 
cocaine was the second most commonly seized 
drug after cannabis resin. 
Data from the National Drug Treatment Reporting 
System (NDTRS) presented in the report are 
representative of people who attend for treatment 
for problem cocaine use, rather than of the general 
population using cocaine. Analysis of this data 
indicates a sustained increase between 1998 and 
2003 in the number of treated cases reporting 
cocaine as a problem drug. The number of treated 
cases reporting cocaine as a main problem drug 
increased by 262%, from 86 in 1998 to 311 in 
2003. The number of cases reporting cocaine as 
an additional problem drug increased by 394%, 
from 454 in 1998 to 2,244 in 2003. The majority 
(92%) of cases reporting cocaine as their main 
problem drug in 2003 used one or more additional 
drugs. Cannabis, alcohol and ecstasy were the most 
common additional drugs reported among these 
cases. Cocaine was reported as an additional drug 
in cases where opiates, cannabis or ecstasy were 
reported as the main problem drug. Data presented 
from the Hospital In-Patient Enquiry System 
(HIPE) also indicate an increase in the number 
of cases treated for cocaine-related problems in 
the years up to 2004. In relation to the method 
of administration reported by people attending 
treatment for cocaine use, 70% reported snorting, 
17% reported injecting and 11% reported smoking 
cocaine.
According to the authors, evidence from the data 
collected in the Research Outcome Study in Ireland 
(ROSIE), for which the study sample consists of 
problem opiate users in treatment, suggests that 
current treatment services have contributed to 
reducing both opiate use and cocaine use. The 
authors report that, although no pharmacological 
substitution treatment is available for cocaine 
use, existing evidence indicates that many 
approaches currently being practised in treatment 
services, such as cognitive behavioural therapy, 
brief interventions, group therapy/counselling, 
contingency management, and peer leadership, 
work well with cocaine users. However, the authors 
state that current treatment services require a 
more cocaine-specific focus in order to encourage 
cocaine users to avail of such services. 
At the launch of this report, Dr Corrigan 
highlighted the impact cocaine is having in the 
community, in terms of sharp increases in public 
disturbance, noise, intimidation and violence, 
while individuals are experiencing disrupted 
personal relationships, reduced productivity, loss of 
employment and income as well as physical and/or 
mental ill-health. Physical problems, including 
heart conditions, strokes, nasal damage and 
breathing problems, are associated with cocaine 
use. Intravenous cocaine use can lead to abscesses, 
blood clots and a range of systemic infections, 
including HIV and hepatitis B and C. Mental health 
problems include depression, agitation, anxiety, 
compulsive behaviour, aggression and paranoia. 
The authors report that levels of alcohol use among 
cocaine users are high. Alcohol and cocaine, when 
used together, combine to form a more toxic 
substance called cocaethylene.
The report makes 13 recommendations, focusing 
mainly on treatment but also covering supply, 
prevention and research. Those relating to 
treatment include:
Establish stimulant-specific interventions in 
areas where cocaine problems are acute. 
■
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Re-orient drug treatment services from drug-
specific interventions to treatment tailored 
towards the individual regardless of the drug(s) 
they use.
Dispel the myth that there is no effective 
treatment for cocaine use.
Launch needle-exchange and related harm-
reduction strategies.
Identify and meet training needs of frontline 
staff. 
Improve working relationships between GPs, 
A&E staff and the drug services.
Include cocaine among the problem drugs 
addressed by prison drug treatment services 
and drug awareness programmes. 
(Ena Lynn)
■
■
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1.  National Advisory Committee on Drugs and 
the National Drugs Strategy Team (2007) An 
overview of cocaine use in Ireland: II. Dublin: 
Stationery Office. www.nacd.ie 
2.  National Advisory Committee on Drugs (2003) 
An overview of cocaine use in Ireland. Dublin: 
Stationery Office. www.nacd.ie
3.  National Advisory Committee on Drugs and 
Drug and Alcohol Information Research Unit 
(2006) Drug use in Ireland and Northern Ireland. 
2002/2003 drug prevalence survey: cocaine results. 
Bulletin 4. Dublin: National Advisory Committee 
on Drugs.
4.  Health Promotion Unit (2005) The health of Irish 
students. Dublin: Department of Health and 
Children.
5.  Centre for Health Promotion Studies, NUI Galway 
(2003) Survey of lifestyle, attitudes and nutrition 
(SLAN) and the Irish health behaviour in school-
aged children (HBSC) survey. Dublin: Department 
of Health and Children.
Overview of cocaine use (continued)
Evaluation of projects to treat 
cocaine users
In 2004, the Department of Community, Rural 
and Gaeltacht Affairs requested the National Drugs 
Strategy Team (NDST) to identify projects that 
would tackle the growing problem of cocaine 
misuse in Ireland. In response, the NDST established 
the Cocaine Sub-Group to recommend pilot 
interventions aimed at different types of cocaine 
users.
The three pilot treatment interventions selected were: 
A community-based project involving St 
Dominic’s Community Response Project and 
Killinarden’s Community Addiction Response 
Programme, Tallaght, for problematic intranasal 
cocaine users.1 The interventions planned were 
advertising service availability, project meetings, 
relationship building, individual care plans, 
individual counselling, and holistic therapies. 
Three inter-disciplinary, evidence-based 
interventions at Castle Street Clinic in the HSE 
South Western Area for polydrug users.2 The 
planned interventions employed a combination 
of individual and group counselling and cognitive 
behavioural therapy approaches. 
A peer-support training project in the Women’s 
Health Project, Baggot Street and in Chrysalis, 
Benburb Street, for women using cocaine and 
working in the sex industry.3 It was envisaged 
that the project would train participants to 
provide accurate information on sexual health 
and drug use to their peers. 
A fourth project, selected and implemented by 
Merchants Quay Ireland,4 involved the provision of 
Tier 1 and Tier 2 training for health and social care 
■
■
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staff working with cocaine users. The results of the 
training evaluation are not presented in this article.
Goodbody Economic Consultants were appointed as 
external evaluators for the pilot treatment projects. 
In addition, the management committee for the 
Women’s Health Project decided to conduct an 
internal evaluation. The objectives of the external 
evaluation were to analyse what was achieved by the 
projects and report the lessons learned. In order to do 
this, the evaluators were to examine the structures, 
effectiveness, efficiency and value for money 
components of the projects. 
The project based in Tallaght was implemented 
in line with its original design. It commenced in 
February 2005 and ended in April 2006. The project 
employed six staff members on a part-time basis. 
The service was provided through two evening 
sessions and one afternoon session. The cocaine 
treatment service was promoted through a media 
campaign and proactive outreach work. The project 
communicated with cocaine users and concerned 
persons by telephone and received an average of 20 
calls per week. Ninety-nine cocaine users attended 
the project, of whom 60 (61%) returned more than 
once. The uptake of complementary treatments, such 
as acupuncture and Indian head massage, was high. 
A further 60 people were assisted by the outreach 
worker. Seven clients were interviewed at the end of 
the project, of whom four were abstinent from all 
drugs and two said that their suicidal thoughts had 
ceased. According to the evaluators, the project was 
effective and very good value for money. 
At the implementation stage, the intervention for 
the project based in Castle Street was modified 
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to provide participants with a group counselling 
programme consisting of a 90-minute session each week 
for 12 weeks. The topics for the counselling sessions 
were: understanding addiction, process of recovery, 
managing cravings, healthy relationships, self-help 
groups, support systems, managing feelings and coping 
with guilt and shame. It was envisaged that three groups 
of 12 cocaine users would complete the programme. 
The project was implemented in 2005 and used existing 
staff resources. Two group counselling programmes 
were completed during the pilot period. Twenty-six 
polydrug users were referred to the project, of whom 14 
were considered suitable to attend. Of the attendees, six 
completed the programme and five completed the post-
intervention assessment. Of the five attendees assessed, 
one was abstinent from all drugs, two had reduced their 
cocaine and alcohol use, and two had reduced their 
cocaine use but not their alcohol use. The evaluators 
identified a number of weaknesses in the project design 
and implementation. The selection and referral process 
had serious flaws in that a high number of those referred 
were not suitable for the programme. The gap between 
counselling sessions was too long. Active drug users 
and those who were abstinent attended the same 
programme and this caused conflict. After-care was 
provided only to those who attended the second group 
and uptake was low. The programme design did not take 
account of the participants’ other commitments (such as 
child care, training and employment) and this reduced 
attendance. There was no leadership or administrative 
support provided for the programme and the monetary 
resources allocated were not used. The evaluators 
recommended that this approach to cocaine treatment 
had merit but that the weaknesses identified must be 
addressed in any future programmes. 
The project based in both Baggot Street and 
Benburb Street changed its original objective from 
one of encouraging peer support to that of identifying 
participants who would invite other women (peers) to 
information and/or complementary therapy sessions. 
The topics for the information sessions were: harm 
reduction, working in a safe environment, general and 
sexual health, hepatitis C, effects of cocaine use and 
effects of complementary therapy. The complementary 
therapies were acupuncture, Indian head massage, 
Reiki, stress balls and upper body massage. The project 
management committee employed an experienced 
outreach worker on a part-time basis and introduced a 
complex system of payments for those attending the 
project. The project commenced in October 2005. 
Twenty-two women were contacted through the project, 
of whom 18 (7 participants and 11 peers) attended at 
least one project activity. Attendance at complementary 
services was better than that at information sessions, 
which did not hold the interest of the women; according 
to the external evaluators, this may have been linked to 
rates of payment. During the course of the project, it was 
observed that many of the women had complex social 
and medical problems and the project activities were 
not broad enough to address such issues. The outreach 
worker did address some of these problems through 
referrals to and negotiations with other services. The 
external evaluators reported that they could not form a 
judgement as to whether this project was effective or not 
without knowing the results of the internal evaluation. 
(Jean Long)
1.  Goodbody Economic Consultants (2006) Evaluation of 
the pilot cocaine project in Tallaght. Dublin: Department 
of Community, Rural and Gaeltacht Affairs. 
2.  Goodbody Economic Consultants (2006) Evaluation of 
the pilot cocaine project in Castle Street Clinic. Dublin: 
Department of Community, Rural and Gaeltacht 
Affairs.
3.  Goodbody Economic Consultants (2006) Evaluation 
of the pilot cocaine Women’s Health Project. Dublin: 
Department of Community, Rural and Gaeltacht 
Affairs.
4.  Crampton W (2005) An evaluation of a cocaine training 
programme. Dublin: Merchants Quay Ireland.
All four evaluation documents are available at 
http://www.pobail.ie/en/NationalDrugsStrategy/
EvaluationsofthePilotCocaineProposals/
Crack cocaine workshop 
On 3 April 2007, URRÚS, a community addiction studies 
training centre in Ballymun, held a training workshop 
on crack cocaine. The workshop was facilitated by Greg 
Christodoulou and focused on a number of key areas:
the history of crack cocaine 
the physical and psychological effects of the drug 
the outcomes of short- and long-term use
effective intervention therapies. 
A number of key points emerged from the workshop: 
Crack cocaine, first developed in the 1970s, is 
produced from cocaine powder mixed with 
substances such as ammonia or sodium bicarbonate 
and then heated. The resulting substance solidifies 
into a rock form enabling it to be smoked. 
Crack cocaine is purer than cocaine powder and 
provides an immediate and intense experience for 
the user. 
■
■
■
■
■
■
Crack is considered to be psychologically, rather 
than physically, addictive. The physical effects 
of frequent and long-term use of crack cocaine 
include respiratory problems, such as bronchitis, 
and an increased risk of heart attack and stroke. 
Psychological outcomes include paranoia, 
depression, anxiety and cocaine psychosis. 
There are a number of recognised treatments 
for crack cocaine addiction, including cognitive 
behavioural therapy and non-residential drug-free 
counselling.
(Sinéad Foran)
For further information on the various training courses 
and workshops available, URRÚS can be contacted at 
01- 846 7980 or email urrus@iol.ie.
■
■
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The Research Outcome Study in Ireland (ROSIE) is 
being conducted by a team at the National University 
of Ireland, Maynooth, on behalf of the National 
Advisory Committee on Drugs (NACD). The aim of 
the study is to recruit and follow opiate users entering 
treatment and to document their progress after six 
months, one year and three years. 
At baseline, the study recruited 404 opiate users 
aged 18 years or over entering treatment or, in the 
case of a sub-sample of 26 (6%), attending needle-
exchange services. The participants were engaged in 
one of three different forms of treatment: methadone 
maintenance/reduction (53%, n=215), structured 
detoxification (20%, n=81) and abstinence-based 
treatment (20%, n=82). 
The treatment outcomes presented in the first 
two papers in the ROSIE Findings series have been 
reported in previous issues of Drugnet Ireland. The 
third paper in the series, Findings 3,1 provides 
a summary of the outcomes for people in the 
abstinence modality one year after treatment intake. 
The abstinence modality is defined as: ‘any structured 
programme which required individuals to be 
drug-free (including free from any pharmacological 
intervention) in order to participate in, and remain 
on, the programme’. Participants are required to 
attend a structured programme of daily activities 
and are given intensive psychological support. 
Abstinence-based treatment occurs in both inpatient 
and outpatient settings. Residential rehabilitation 
programmes can differ considerably in terms of their 
underlying philosophy and programme structure. 
Programmes may be either short-term (4–12 weeks) 
or long-term (3–12 months). 
The ROSIE abstinence cohort comprised 82 
individuals, the majority recruited from inpatient 
settings (85%, n=70), with the remainder being 
treated in outpatient settings (15%, n=12). Those 
recruited from inpatient settings were attending one 
of the three main types of residential rehabilitation 
programme identified in the international literature: 
12-step/ Minnesota Model, Christian house or 
therapeutic community. The analysis presented 
in Findings 3 is based on the 56 participants who 
provided valid answers to each individual question 
during their treatment intake and one-year follow-up 
interviews. 
The abstinence participants were typically male 
(89%), had an average age of 27 years and were 
largely dependent on social welfare payments 
(70%). Just less than half (47%) had children but the 
majority (77%) of these did not have their children in 
their care. Most had spent some time in prison (72%) 
and 16% had been homeless in the 90 days prior to 
treatment intake interview. 
Treatment completion rates
The treatment completion rate was high, with 
66% of participants successfully completing their 
abstinence programme (n=37). Just over one-quarter 
of the cohort (27%, n=15) dropped out of treatment, 
2% (n=1) transferred to another treatment type 
before completing the programme and the 
remaining 5% (n=3) were still engaged in their 
treatment programme at one year.
In addition to those still engaged in their abstinence 
treatment programme one year after treatment 
intake, 64% of participants (n=36) reported that 
they were in some form of drug treatment. Less than 
one-quarter of the cohort (23%, n=13) were on a 
methadone programme, 23% (n=13) were attending 
one-to-one counselling and 37% (n=21) were 
attending group work (Narcotics Anonymous (NA) 
meetings, aftercare programmes and structured day 
programmes). 
Drug use outcomes
The number of participants who reported using 
heroin, non-prescribed methadone, non-prescribed 
benzodiazepines, cocaine, cannabis or alcohol in 
the 90 days prior to interview decreased between 
treatment intake and one-year follow-up. The most 
substantial reduction was in cocaine use, in terms 
of the proportion of participants using the drug 
(46% at treatment intake compared with 14% at 
one year), the frequency of use (an average of 10 
out of 90 days at treatment intake compared with 
an average of 2 out of 90 days at one year) and the 
quantities consumed (an average of 1 gram per day 
at treatment intake compared with an average of 0.3 
grams per day at one year). 
Crime outcomes
Overall, the proportion of participants who reported 
no involvement in crime had risen considerably 
at one year (76%) compared to treatment intake 
(43%). There was a reduction in the percentage of 
participants involved in acquisitive crime, from 35% 
(n=19) at treatment intake to 13% (n=7) at one year. 
Risk behaviour outcomes
Findings 3 states that there was a non-significant 
reduction in the number of participants who 
reported injecting drug use. There were no changes 
in participants’ injecting-related risk behaviours. The 
proportion of participants who reported an overdose 
within the previous 90 days remained at 4% (n=2) 
over the two time periods. 
Health outcomes
Ten symptoms were used to measure the physical 
health of participants (see paper for details). The 
number of participants who reported nine of the 
ten physical health symptoms reduced between 
treatment intake and one year. 
ROSIE Findings : summary of 
abstinence treatment outcomes
drugnet 
IRelAND
1
Ten symptoms were also used to measure the mental 
health of participants (see paper for details). There 
was a reduction in the number of participants who 
reported suffering from any five of the ten mental 
health symptoms. 
Service contact
Findings 3 reports an increase in participants’ contact 
with GPs and with employment/ education agencies.
The authors state that the findings presented 
in this paper demonstrate that participation in 
an abstinence-based treatment programme is 
followed by positive outcomes in relation to drug 
use, involvement in crime, and physical and 
mental health symptoms. The outcomes for ROSIE 
participants in abstinence-based treatment compare 
favourably with international outcome studies. As 
noted in the paper, the forthcoming results from 
the ROSIE three-year follow-up will provide stronger 
evidence on the effectiveness of abstinence-based 
treatment programmes and on whether or not 
the improvements observed after one year will be 
sustained. 
(Sarah Fanagan)
1.  Cox G, Comiskey C and Kelly P (2007) ROSIE 
Findings 3: Summary of 1-year outcomes: abstinence 
modality. Dublin: National Advisory Committee on 
Drugs.
ROSIE Findings 3 (continued)
007 National Drug Treatment 
Conference (UK)
The 2007 National Drug Treatment Conference 
was held in London on 15–16 March. Four major 
themes were addressed by the conference: social 
exclusion, poverty and drugs; detox and aftercare; 
legal and political issues for drug treatment; and new 
treatments. 
Mike McCarron, national drugs liaison officer for 
the Scottish Association of Alcohol and Drug Action 
Teams described the association between poverty 
and drug use and said that to tackle drug problems 
you have to deal with the underlying social issues. 
He admitted that to do this would take investment 
that some taxpayers might find unpalatable, but 
said he believed that if the facts were made available 
to them they would see that such investment was 
desirable in the long term. Brian Iddon MP spoke 
of the futility of a ‘War on Drugs’, and said we now 
need a war on the causes of drug misuse, namely 
social exclusion and poverty. He claimed that current 
drug policy merely caused displacement, whether 
of cocaine growers in South America who moved 
production from Columbia to other countries, or of 
users in the UK who switched from illegal drugs to 
prescription drugs which are easily available on the 
internet without regulation. He recommended that 
the current ABC classification of drugs should be 
abandoned and a system introduced that reflects a 
50:50 split between harm to the user and harm to 
the general public. He cited a recent spectrum of 
harm developed by David Nutt and colleagues which 
ranks both alcohol and tobacco among the top ten 
most harmful drugs.
David Best of Birmingham University asked why 
people get so little treatment when we know it gives 
better outcomes, and why much of the treatment 
that is given is not sufficiently intensive. Referring 
to a study of more than 300 patients receiving 
counselling treatment, he demonstrated that the 
average fortnightly sessions, which also involved 
case management as well as advice and support on 
related issues such as housing and employment, 
often meant that clients only received just over 20 
minutes of actual counselling a month, or around 
four hours a year. He spoke of the need to look 
for exits from treatment and to start thinking of 
addiction as a career with a beginning, middle 
and end, not as a permanent chronic condition. 
A number of speakers spoke about detoxification 
and its effectiveness in treating dependence on 
opioid and other illicit drugs, and of the need for 
optimum timing of a detoxification attempt within 
an addiction career. 
The importance of commissioning integrated 
drug and alcohol systems was discussed by Trevor 
McCarthy of the National Treatment Agency (NTA). 
He said that fewer than half of drug users had been 
advised about alcohol during treatment, even though 
alcohol can dramatically increase depression of the 
immune system, as well as producing dangerous 
compounds; for instance, alcohol and cocaine 
produce cocaethylene when metabolised. Michael 
Farrell of the National Addiction Centre said that 
the problem of heavy drinking among those on 
maintenance prescribing is considerable and is 
estimated to occur in approximately 20% of the 
treatment population. He spoke of the need for 
treatment services to determine people’s alcohol 
dependence. He also stressed the importance of 
being able to differentiate between opiate and 
alcohol withdrawal symptoms as ignorance could be 
fatal. Jack Law of Alcohol Focus Scotland spoke of the 
need to focus on harm reduction related to alcohol. 
He attributed problems with young people’s drinking 
to increased acceptability, availability and affordability 
of alcohol. He said that harm reduction interventions 
would need to be pragmatic and strategic, looking 
more seriously at drinking environments, community 
safety initiatives, planning and effective licensing laws 
and better training of licensees. 
(Deirdre Mongan)
Archived material from this conference (NDTC 
07) and from previous events is available on the 
organiser’s website at www.exchangesupplies.org 
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In January 2007 Kilbarrack Coast Community 
Programme (KCCP) published a report entitled 
Forging a new template: proposing a more effective way 
of working with drug users.1 Declan Byrne, the author 
of the report, has worked with KCCP since December 
2000. He was awarded a masters degree in addiction 
studies from Dublin Business School (DBS) in 2005. 
This report is the culmination of his practical and 
academic experiences.
In a foreword to the report, Dr Rick Loose of DBS 
describes addiction and explains the importance of 
creating a transferential space in order to treat it. 
During treatment, addicts are asked to abstain from, 
or put a limit to, the substance they have been using. 
When asked to give up or reduce their intake of the 
problem substance which gives them pleasure (or 
stops pain), addicts will often come to depend on 
a substitute mechanism. Dependency on drugs or 
alcohol is transformed into a dependency on staff 
and/or the treatment centre. Addicts demand from 
the counsellor (or institution) something which drugs 
or alcohol had previously given them. They want to 
regain some of the lost immediacy or satisfaction via 
the transference relationship. 
Addiction treatment relationships involve emotional 
expressions (demands for recognition, trying to 
please, being good, wanting to be loved, accusation, 
irritation, aggression, transgression, behaving badly 
etc.) which are signs of the pathology of the client. 
These emotional expressions are the essence of 
addiction treatment. The only way for addicts to 
recover is via verbalisation within a relationship where 
very difficult and anxiety-provoking experiences can 
be articulated and worked through. 
It is in the very nature of addiction to undermine 
the pact that exists between people. This is what 
counsellors have to withstand and when this 
becomes problematic it can lead to counter-
transference. It often happens that staff are idealised 
by addicts. At an unconscious level staff members 
may identify with this idealisation – there is a need in 
them to be admired by their clients. The treatment 
can become destructive if the counsellor’s need feeds 
into the pathology of the client. This will lead to a 
therapeutic deadlock and the client will be forced to 
remain dependent on the counsellor/institution.
Loose argues that the creation and maintenance of 
a space of transference within society is essential. 
Popular culture advocates the immediacy of 
enjoyment which means that there is less space for 
dissatisfaction, desire and the social bond. This is 
the kind of culture that becomes less demanding 
of its subjects in terms of making them responsible 
for finding solutions to their own suffering and 
increasingly forces external solutions on them. 
In the main body of the report, KCCP is used as a 
case study ‘to demonstrate the need for change 
in the way we work with problematic drug users’. 
The varied lifestyles and circumstances of the 
programme participants are illustrated using the 
data from a general questionnaire administered to 
the 16 participants on the programme in March 
2005. Detailed accounts of the experiences of three 
participants are provided by way of semi-structured 
interview, life history and treatment history. It is 
clear from these examples that the participants have 
different histories and reasons for taking drugs. As a 
result of his own work with clients and his reading 
of the academic literature (see report for details), 
the author advocates an approach to treatment in 
which the treatment programme is tailored to meet 
the needs of the individual, in so far as is possible. 
He highlights the necessity of working with the 
transference that occurs in the treatment of addiction 
and suggests that doing so could significantly 
increase the effectiveness of KCCP.
The author points out that KCCP will not be in 
a position to employ trained psychotherapists 
or psychoanalysts in the short to medium term. 
However, he suggests that a structured training 
programme could enable staff to manage the 
transference/counter-transference in order to help 
their clients. In June 2005 KCCP held a half-day 
training course on the issue of transference/counter-
transference. This was seen as a first step in increasing 
awareness of the issue among staff. The author 
argues that the Health Service Executive (HSE) 
must take more responsibility for the running of 
community drugs programmes. ‘By taking a more 
hands-on approach, they could ensure that all staff 
are professionally trained and that clinical supervision 
is provided.’
The author’s proposed new template:
The management of transference should be 
placed at the centre of KCCP’s programme.
Training in transference/counter-transference 
should be prioritised and funded for all staff 
working with clients.
External supervision must be provided for staff.
Additional funding should be sought to employ 
a psychotherapist to work with clients who have 
severe problems, particularly those with dual 
diagnosis and trauma histories. 
(Sarah Fanagan)
1.  Byrne D (2007) Forging a new template: proposing 
a more effective way of working with drug users. 
Dublin: Kilbarrack Coast Community Programme 
Ltd.
■
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The Homeless Agency recently launched its action 
plan1 to eliminate long-term homelessness2 and the 
need to sleep rough3 in Dublin by 2010. This article 
will discuss the elements of the plan that relate to 
homeless individuals with addiction problems in 
the context of the wider policy framework on drugs 
and homelessness. 
The plan contains three strategic aims, relating to 
prevention, local access to quality homeless services 
and long-term housing options with support 
when required. The plan contains 10 core actions 
(high priority) that cover more than one strategic 
aim and 74 additional actions (lower priority). 
Individuals with mental health problems, addictions 
(alcohol and drugs) and dual diagnosis (addiction 
and mental health) needs have been identified as 
needing healthcare and other interventions as part 
of the strategic aim to prevent homelessness and 
reduce the risk of becoming homeless. 
As part of the development of the action plan, 
a total of 105 men, women and children, both 
current and past users of homeless services, were 
interviewed. The principal immediate causes of 
their becoming homeless were identified by those 
interviewed as family breakdown, and alcohol, 
heroin and mental health problems. Several 
studies have shown the prominent role played by 
drug use in exposing individuals and families to 
homelessness in Ireland.4,5,6,7 
When asked to comment on existing homeless 
and housing services, interviewees mentioned 
the shortage of treatment/detox beds, as well as 
the impossibility of giving up drink or drugs while 
on the streets. The importance of appropriate 
accommodation, including transitional housing, 
after treatment and/or detoxification was 
emphasised as a first step in relapse prevention. 
There were repeated calls for ‘dry’ hostels for 
homeless people wishing to be drug or alcohol free 
and ‘wet’ hostels for those unable or unwilling to 
remain abstinent. 
By way of addressing some of these issues, the 
action plan states: 
The Health Service Executive and National 
Drugs Strategy Team (with the Department of 
Community, Rural and Gaeltacht Affairs) will 
develop a national plan for the expansion of 
detox and rehabilitation services for active drug 
users, arising from the recommendations from 
consultations currently taking place. (p. 51) 
The issue of residential treatment capacity also 
arose during the recent deliberations of the 
Working Group on Drugs Rehabilitation. In 
response, the Health Service Executive (HSE) 
established a working group in September 2006 to 
examine the issue in depth. As an interim measure, 
the Working Group on Drugs Rehabilitation 
recommends an increase in the current stock of 
residential detoxification beds from 23 to 48.8
Also essential, in terms of relapse prevention 
and progress towards social reintegration, is the 
provision of transitional housing supports following 
treatment/detox and, indeed, this was stressed 
by those participating in the development of 
the action plan. Action 61 of the National Drugs 
Strategy identifies the need to provide a range of 
respite places and half-way houses.9
However, the mid-term review of the Strategy10 
noted that ‘considerably more progress’ was 
required on this action. Nonetheless, some efforts 
have been made to provide transitional housing 
for individuals coming out of residential treatment, 
for example those by Merchants Quay Ireland and 
the Arrupe Society. A pilot step-down housing 
programme, set up in 2005 in a partnership 
between Focus Ireland and the Keltoi project, 
is to be evaluated shortly. The recent report of 
the Working Group on Drugs Rehabilitation 
recommends that the Department of Environment, 
Heritage and Local Government take the lead in 
providing transitional and half-way housing for 
recovering drug users. 
Individuals with mental health problems, addictions 
(alcohol and drugs) and dual diagnosis (addiction 
and mental health) have been identified in the 
Homeless Agency plan as needing healthcare and 
other supportive measures to prevent homelessness 
and reduce the risk of becoming homeless. 
Courtney (2005),11 in a review of temporary 
accommodation services for homeless people, 
noted an increase in referrals of those with multiple 
needs, usually involving substance abuse and 
physical or mental health problems. 
The Homeless Agency’s action plan and Preventing 
Homelessness,12 as well as the Report of the 
Working Group on Drugs Rehabilitation, emphasise 
the challenge of improving inter-agency working 
between the statutory, voluntary and community 
sectors in responding to the needs of individuals 
with addiction and accommodation problems. 
In addition, there is a requirement for structural 
changes to housing and accommodation provision, 
to cater for people who have been through the 
mental health and addiction services and are 
moving towards independent living. The challenge 
facing the Homeless Agency and its partners 
A key to the door – Homeless 
Agency Partnership action plan 
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in delivering on the strategic aim of providing 
long-term appropriate housing and supports is 
acknowledged in the plan: 
The success or failure of the Homeless Agency 
Partnership Action Plan is dependent on a 
dramatic increase over the next four years of 
secure and sustainable housing for people who 
are homeless. (p. 53) 
(Martin Keane)
1.   Homeless Agency (2007) A key to the door: 
the Homeless Agency Partnership action plan 
on homelessness in Dublin 2007–2010. Dublin: 
Homeless Agency.
2.   Long-term homelessness is defined as the state 
of being homeless for over six months. For a 
definition of homelessness, see the Housing Act 
1988, section 2.
3.   The need to sleep rough occurs when there is a 
lack of emergency accommodation appropriate 
to a person’s needs.
4.   Houghton FT and Hickey C (2000) Focusing on 
B&Bs: the unacceptable growth of emergency B&B 
placement in Dublin. Dublin: Focus Ireland.
5.   Feeney A, McGee H, Holohan T and Shannon W 
(2000) Health of hostel-dwelling men in Dublin. 
Dublin: Royal College of Surgeons in Ireland 
and Eastern Health Board.
6.   Halpenny AM, Keogh AF and Gilligan R (2002) 
A place for families? Children in families living in 
emergency accommodation. Dublin: Homeless 
Agency.
7.   Lawless M and Corr C (2005) Drug use among 
the homeless population in Ireland: a report 
for the National Advisory Committee on Drugs. 
Dublin: Stationery Office.
8.   Working Group on Drugs Rehabilitation 
(2007) Report of the working group on drugs 
rehabilitation, May 2007. Dublin: Department of 
Community, Rural and Gaeltacht Affairs.
9.   Department of Tourism, Sport and Recreation 
(2001) Building on experience: National Drugs 
Strategy 2001–2008. Dublin: Stationery Office.
10.  Steering group for the mid-term review of the 
National Drugs Strategy (2005) Mid-term review 
of the National Drugs Strategy 2001–2008. 
Dublin: Department of Community, Rural and 
Gaeltacht Affairs.
11.  Courtney R (2005) Review of temporary 
accommodation. Dublin: Homeless Agency.
12.  Pillinger J (2006) Preventing homelessness: a 
comprehensive preventative strategy to prevent 
homelessness in Dublin, 2005–2010. Dublin: 
Homeless Agency.
Homeless Agency Action Plan (continued)
A recent report by McGrath and Lynch1 highlights 
the lack of suitable recreational facilities and 
spaces for young people in East Cork. The report 
is based on a process of engagement with young 
people aged 13–18 attending secondary schools, 
youth projects and Youthreach, which included an 
exploratory survey, validation groups and a youth 
conference. The aim of this engagement process 
was to ascertain the views of young people on 
recreational facilities and spaces in East Cork. 
The survey consisted of three questions that invited 
‘open responses’. A total of 702 young people 
responded to the survey. The researchers also 
conducted validation groups with some of the 
young respondents to discuss and develop some of 
the issues raised in the survey. 
Seventy-nine per cent of the young people 
replied ‘No’ to the question ‘Are there adequate 
recreational facilities in your area?’ and, according 
to the authors, many replies were conveyed 
in emphatic terms using capital letters and 
exclamation marks. Replies included references to 
young people drinking alcohol, smoking tobacco 
and using other drugs to ‘relieve boredom’ in 
the absence of adequate facilities. Some replies 
highlighted the prohibitively high cost of using 
sports facilities and going to the cinema. 
When asked ‘When you go out, where do you go?’, 
82.2% replied that they ‘hang around’ with peers, 
often despite the disapproval of their parents. In 
elaborating further, 37.9% stated that they hung 
around the town centres and streets, 16% at 
friends’ houses and 15.6% in shops or shopping 
centres. 
When invited to identify what they would like to 
see happening in their areas for young people in 
the future, respondents said they would like more 
recreational facilities, including cinema, leisure 
centre/arcade, pool hall and restaurants (35.6%); 
sports facilities, including swimming pool and 
Astroturf (24%); and a place to ‘hang around’ 
(22.9%). 
‘Hanging around’ with peers is a key theme 
throughout this research with young people, in 
terms of both what they do and what they need 
Young people’s views on 
recreational facilities in East Cork
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recreational space for. This theme of ‘hanging 
around’ as a particular need for young people 
is reflected in similar research and consultations 
with young people in Ireland. For example, 
‘hanging around’ was identified as an important 
leisure activity by 90% of respondents in a survey 
of 2,260 12–18-year-olds from 51 schools in 
Ireland.2 Research by Devlin3 and Lalor and Baird4 
also highlighted ‘hanging around’ with peers 
as a favoured activity among young teenagers 
in Ireland. In addition, the report of the public 
consultation on the proposed national recreation 
policy for young people5 identified the provision 
of more recreational facilities as the single biggest 
need identified, with somewhere to go and ‘hang 
out’ with friends the most requested recreational 
facility. 
This report found that ‘youth cafés’ were a favoured 
option among young people as a place to ‘hang 
out’ with their peers. According to a recent report 
in the Irish Times (4 January 2007), the forthcoming 
national recreation policy for young people will 
include provisions for a network of youth café-type 
facilities throughout the country. It appears that 
what makes these youth cafés a popular option 
among young people is that they provide an 
alcohol and drug-free environment, they provide 
for unstructured ‘hanging out’ space, they are 
cheap to use and provide a safe space to mix with 
peers. 
Two key messages emerging from this report 
reflect the findings of other Irish studies and the 
results of the public consultation on the proposed 
national recreation policy. First, the need for young 
people to be provided with adequate recreational 
space such as youth cafés to ‘hang out’ with their 
friends is one that parents, youth workers and 
policy makers can no longer ignore. The provision 
of additional recreational facilities, such as music 
or sports venues, can be developed in partnership 
with the young people from the initial reference of 
the youth café. Second, this a good opportunity for 
policy makers to take on board the findings from 
research and base their decisions on these findings. 
If, as seems likely, they respond to this challenge, 
the pursuit of evidence-based policy will have 
received a welcome boost. 
(Martin Keane)
1.  McGrath M and Lynch D (2007) Where do you go 
when you go out? Young people’s views on youth 
friendly facilities in East Cork. Cork: East Cork Area 
Development Ltd. 
2.  de Róiste A and Dinneen J (2005) Young people’s 
views about opportunities, barriers and supports to 
recreation and leisure. Dublin: National Children’s 
Office.
3.  Devlin M (2006) Inequality and the stereotyping of 
young people. Dublin: The Equality Authority.
4.  Lalor K and Baird K (2006) Our views – Anybody 
listening? Researching the views and needs of 
young people in Co Kildare. Kildare: Kildare Youth 
Services.
5.  Office of the Minister for Children (2006) 
The report of the public consultation for the 
development of the national recreation policy for 
young people. Dublin: Stationery Office.
Views on youth facilities in East Cork (continued)
Families coping with heroin use
Launched on 4 April 
2007, the report 
of research by the 
National Advisory 
Committee on 
Drugs (NACD) 
supports the 
inclusion of the 
families of heroin 
users in the overall 
treatment response. 
The main goal 
of this study by 
Duggan1 was to 
develop a greater 
understanding 
of the ways in which families, and in particular 
primary carers, seek support in coping with heroin 
use in their families. The research also examined 
carers’ expectations and perceptions of the 
effectiveness of the support provided. 
The research used in-depth interviews with the 
primary carer, in most cases a parent, and usually 
the mother, in 30 families coping with heroin use. 
These were augmented by interviews with another 
family member in the case of seven families. The 
families were accessed through existing family 
support groups. 
Coping with heroin use in the family
The study identified seven different stages of 
families’ engagement with heroin use in their 
family. The overall direction of this process was 
from powerlessness to empowerment. The different 
stages were: 
1. Ignorance, confusion and denial
2. Coping alone
3. Desperately seeking help
4.  Learning about heroin use and getting personal 
support
5. Supporting non-heroin-using family members
6. Supporting the heroin user in recovery
7.  Supporting the community response to heroin use
This report found 
that ‘youth cafés’ 
were a favoured 
option among 
young people as a 
place to ‘hang out’ 
with their peers.
Seeking help to cope with heroin use in the 
family
Three specific ways of interacting with services 
were identified, reflecting three different roles that 
families occupied. These were: 
As victims: non-heroin-using family members 
sought support for themselves in coping with 
the problems experienced due to heroin use in 
the family. 
As carers: families, particularly the primary 
carers, sought support for the heroin user. 
As agents of recovery: families sought to 
support the user into recovery and address their 
own needs as a family.
Experiences of generic health services
Hospitals were complimented on their responses 
to the crisis needs of drug users, their children 
and other family members. However, interviewees 
reported that hospitals were poor in providing 
follow-up support or information on referral to 
support services.
Interviewees reported that general practitioners 
were often the first point of contact for family 
members seeking help. Responses from GPs 
varied, with some being of little assistance and 
others giving valuable information and advice to 
family members and, often, the heroin user. These 
responses demonstrate the need for standardised 
protocols governing the provision of information 
and support to families seeking help with heroin 
use through their GPs. 
Experiences of the criminal justice system
Families reported their contact with the criminal 
justice system to be ongoing and generally 
favourable. Gardaí in rural areas and judges were 
seen as sympathetic. The probation service was 
complimented for its constant and effective support 
for both the heroin user and the family. 
Experiences with specialist drug services
Drug counsellors were considered helpful and 
effective for both the heroin user and the family. 
Treatment centres were acknowledged for treating 
the user, but the effectiveness of the treatment 
was not always evident to the families. In addition, 
there was a perception among family members 
that treatment centres did not favour including 
the family in the treatment process and often 
maintained a distance from the family. 
Families acknowledged the role played by 
methadone treatment in reducing anti-social 
behaviour among heroin users. However, in 
general, families were critical of methadone 
treatment services and were of the view that 
not enough information was provided about the 
implications of going on methadone. Families 
criticised the absence of alternative treatments and 
expressed the view that methadone maintenance 
programmes were not conducive to progression to 
abstinence and reintegration.
■
■
■
Community Drug Teams (CDTs) were highly 
regarded by those who reported contact with 
them; however, the view was expressed that 
CDTs should be available for longer hours and at 
weekends. Family support groups were also highly 
rated by families; contact with these groups often 
marked a turning point in empowering the families 
to respond to heroin use in their family. 
Barriers to accessing support
The stereotypical view of heroin use as a problem 
primarily associated with urban disadvantage often 
meant that rural families were slow to recognise the 
problem in their own families and less inclined to 
accept the problem as something prevalent in their 
communities. 
When initially faced with the problem of heroin use 
by a family member, families often experienced 
shame and denial due to the perceived social 
stigma that surrounds heroin use. This had 
implications for the speed with which they sought 
help from external sources. 
At almost every stage of coping with the problem 
of heroin use, family members were confronted 
with a lack of information on the type of help they 
needed, where they could access it and how they 
could assess its effectiveness. 
This is an important and relevant piece of research 
as it identifies both the difficulties experienced by 
families seeking to cope with heroin use and access 
services and the positive role that families can 
play in the treatment of the heroin user. Clearly, 
families need better information and support when 
confronted with heroin use in their family. Also, 
specialist drug treatment providers, including 
general practitioners, need to consider the role that 
families can play in the treatment plans of clients. 
Report’s key recommendations to policy makers 
and practitioners 
Recognise, value and resource the role of peer-
led family support groups in assisting families in 
coping with heroin use.
Deploy specialist personnel at local level to 
provide ongoing support to drug users and 
ongoing liaison with their families.
Establish formal links between family support 
groups and drug treatment specialist personnel.
All generic service providers should develop 
codes of practice in relation to information 
provision to families affected by heroin use.
Acknowledge, in policy and practice, the spatial 
and social diversity of heroin use. 
(Martin Keane)
1.  Duggan C (2007) The experiences of families 
seeking support in coping with heroin use. Dublin: 
Stationery Office.
■
■
■
■
■
Families coping with heroin use (continued)
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On 16 April 2007 ‘Drugs – a new deal’, a 
campaign calling for action by government 
and state agencies, was launched by CityWide, 
an organisation which supports a network of 
community groups throughout the country 
working to tackle the drugs problem. In its 
summary report of the launch1 CityWide states: 
‘Despite the significant progress that has been 
made since the National Drugs Strategy (NDS) was 
first established in 1996, we now face a problem 
that is continuing to escalate and that is damaging 
the lives of more and more people, more and 
more families, more and more communities’. The 
report proceeds to call for a ‘new deal to be put 
in place between the government, the state and 
local communities that recognises the scale and 
seriousness of the problem that is facing us all’. The 
‘Drugs – a new deal’ campaign makes seven key 
demands of central government. These are listed in 
the summary report:
‘Implement the National Drugs Strategy 
2001-2008.’ According to CityWide, key 
commitments given as part of the NDS have 
not yet been met. The organisation wants 
‘an immediate plan on how to fast track the 
implementation of all remaining actions’.
‘Reinstate a full-time Government Minister 
with sole responsibility for the National 
Drugs Strategy.’ As reported on p. 1, the new 
Minister of State appointed on 20 June, Pat 
Carey TD, has responsibility for drugs strategy 
and community affairs, both included within 
the one ministerial portfolio. 
‘Make adequate budgets available to 
both Local Drug Task Forces (LDTFs) and 
Regional Drug Task Forces (RDTFs) for the 
development of drug services to respond 
to the crises in both heroin and cocaine 
use.’ According to CityWide, the budget for 
2007 allocated no additional funding for the 
provision of new services in LDTF areas, despite 
what it refers to as ‘the growing cocaine 
problem, as highlighted in the recent NACD 
report,2 and the continuing heroin crisis’.
‘Make available an immediate budget for the 
implementation of recommendations in the 
Rehabilitation Report.’ A rehabilitation report 
was published in early June by the Department 
of Community, Rural and Gaeltacht Affairs. It 
makes recommendations for the development 
of rehabilitation services for drug users. 
CityWide is calling for adequate resources to be 
set aside to fund these recommendations.
■
■
■
■
‘Implement immediately the action on 
setting up local Community Policing Fora.’ 
According to CityWide, people living in local 
communities affected by drug use have serious 
concerns around issues of personal safety and 
security. CityWide claims that the NDS provides 
for the establishment of Community Policing 
Fora (CPF) in 14 areas, but to date only three 
have been put in place.3 The organisation is 
calling for the remaining CPFs to be established. 
‘Commit to working in full partnership with 
local communities that are devastated by the 
drugs crisis.’ CityWide claims that in recent 
years there has been an ‘undermining of the 
local structures by central government’, and 
states that the government needs to display ‘ 
a commitment to re-engaging the community 
again, as happened in 1996’.
‘Provide support for families to be involved 
as partners at LDTF and RDTF.’ CityWide 
claims that ‘family members have been among 
the most active members of the community in 
responding to the drugs crisis’, and they state 
that this contribution from families ‘needs to 
be recognised through their involvement in the 
local structures’. 
In the run-up to the recent general election, 
CityWide called for whatever party was elected to 
government to give an urgent political response 
to the drugs crisis. Speaking at the launch were 
a number of prominent politicians, including the 
Labour Party leader Pat Rabbitte TD, Fine Gael TD 
Damien English, Sinn Fein TD Aengus O Snodaigh, 
Socialist Party TD Joe Higgins and Independent TD 
Finian McGrath. The government was represented 
by Fianna Fáil senator, Cyprian Brady. 
Issues raised at the launch included the increased 
prevalence of both cocaine and benzodiazepines 
within communities and the associated problems. 
The problem of alcohol misuse was also mentioned, 
as was the issue of waiting lists for methadone 
maintenance, with particular reference to the 
Ballyfermot area. 
(Johnny Connolly and Angela Morgan)
1.  CityWide (2007) Summary of ‘Drugs – a new 
deal’ campaign launch. Retrieved 4 May 
2007 from www.citywide.ie/resources/
pubs/20070326162045.html 
2.  National Advisory Committee on Drugs and 
the National Drugs Strategy Team (2007) An 
overview of cocaine use in Ireland: II. Dublin: 
Stationery Office.
3.  CityWide (2007) Election 07: drugs in local 
communities. Retrieved 4 May 2007 from www.
citywide.ie/download/doc/election_07.doc
■
■
■
CityWide seeks new deal on drugs
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In March 2006 the HSE published the results of an 
18-month long process evaluation and treatment 
outcome study of female drug-using prisoners 
admitted to the Dóchas Centre, Mountjoy Prison, 
Dublin.1 Dr Catherine Comiskey, the principal 
investigator, presented the main findings of the study 
in the offices of the Women’s Health Council. 
The aim of the study was to model the care pathway 
of the women and to discover whether their 
experiences in the Dóchas Centre had a positive 
or negative impact on their lives. Forty drug-using 
women admitted to the Dóchas Centre between May 
2003 and January 2004 were recruited to take part in 
the longitudinal survey. The women were interviewed 
within one month of committal and again six months 
later. Qualitative interviews were also conducted with 
eight participants working in a number of capacities 
with women who had been in prison. 
Of the original cohort of 40 women who participated 
in baseline interviews, outcome data was obtained 
for 39 women and 27 women completed a second 
interview. The women ranged in age from 16 to 43 
years; 23 had children under the age of 18, most of 
whom did not live with their mothers. The majority 
of the women had completed their education by the 
age of 15. The main findings of the report are outlined 
below. 
The study measured key variables, including drug use, 
accommodation, health, psychosocial functioning 
and involvement in crime before the women 
were admitted to the Dóchas Centre, during their 
imprisonment and after their release. The strongest 
positive outcomes were in the area of crime. There 
was a significant reduction in the overall proportion of 
women committing crimes between baseline interview 
and six-month follow-up. The one exception to this 
was the crime of soliciting, with results at follow-up 
indicating a slightly increased incidence. 
There were varying improvements in the extent of 
drug use among the sample population. The most 
positive of these was a significant reduction in the 
levels of heroin use. On average, the women who 
were using heroin at recruitment stage were using 
it at least once a day. At six-month follow-up this 
had reduced to twice a week. Slight reductions were 
also noted in the numbers of women using cocaine, 
non-prescription methadone and ecstasy. The physical 
and mental health of the women showed only minor 
improvements at follow-up and, in some cases, there 
was evidence of deterioration. Of particular concern 
was the finding that three of the women interviewed 
had attempted suicide since leaving prison. 
One of the main findings of this study was that the 
women were exposed to considerable risks upon 
their release from the Dóchas Centre. The women’s 
experiences on release included overdose, gang rape, 
prostitution, homelessness and polydrug use. Of the 
22 women who were released from prison during the 
six-month follow-up period, only seven returned home 
and did not report any trauma. Three of the original 
cohort of 40 women died during the six-month follow-
up period. All three of these women had been released 
from the Dóchas Centre. This finding demonstrates 
the real and significant risks associated with the period 
following the release of female drug-using prisoners. 
The majority of women who were interviewed at 
six-month follow-up felt that the time which they 
spent in the Dóchas Centre had been of some help. 
The ways in which the prison helped varied for each 
woman and included assistance with drug treatment, 
educational opportunities and a break from the stress 
of their lives. Despite these positive experiences, the 
women expressed a number of negative criticisms of 
the services they received. Over half of the women 
had concerns at the time of their release relating 
to, for example, a lack of suitable accommodation, 
money worries, concerns surrounding their children 
and a fear of returning to drug use. The women 
were asked whether they had received help with 
these issues upon being released. Of the 20 women 
who answered the question, only three had received 
assistance. In addition to this, only four of the 27 
women interviewed at follow-up stated that they had 
had any contact with social welfare services while in 
prison. Finally, 16 of the 22 women who were released 
during the time between baseline interview and 
follow-up were not given advanced indication of their 
release date, which had implications for the women’s 
vulnerability to risks upon release. 
A key finding that emerged from the qualitative 
interviews with the eight participants who worked 
with women who had been in prison was the lack of 
co-ordination between the various in-reach services to 
the women’s prison. These participants felt that, while 
the current range and number of agencies providing 
in-reach services was sufficient, the lack of integration 
between the services often resulted in poorer 
outcomes for the women. They stressed the need for 
appropriate accommodation that took into account 
the specific requirements of drug-using women who 
had been in prison.
The findings of the study indicate that the women 
experienced some positive effects in their lives in the 
six-month period between recruitment and follow-up 
interviews. It is unclear whether the improvements 
noted in the report can be attributed to the Dóchas 
Centre or to the stage which the women were at in 
their drug-using careers. The authors suggest that 
further longitudinal information on the women and 
their care processes would be required in order to 
clarify this. 
(Sinéad Foran) 
1.  Comiskey CM, O’Sulllivan K and Cronley J (2006) 
Hazardous journeys to better places. Dublin: Health 
Service Executive.
Dóchas Centre: process evaluation 
and treatment outcome study
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In February 2007 the European Foundation of 
Drug Helplines (FESAT) published the results 
from its twelfth monitoring project.1 Since the 
beginning of 2001 FESAT has been collecting 
information every six months on the types of 
person contacting helplines, the content of 
these calls and how this has changed compared 
to the previous six months. According to the 
author, the main objective of this monitoring is 
to identify the emergence of new drugs and new 
drug trends; the data cannot quantify the size of 
any such changes. 
Of the 35 relevant FESAT helplines, 18 helplines 
in 14 European countries, including Ireland, 
participated in the project. This article will 
describe some of the main changes that were 
reported by the helplines in Europe during 
the first half of 2006 when compared to the 
second half of 2005. The article presents some 
unpublished information from the Drugs/HIV 
Helpline in Ireland. 
The smallest of the 18 participating helplines in 
Europe answered an average of one call per day, 
and the largest, 130. Seven helplines answered 
10 calls or fewer per day; eight helplines 
answered 11 to 30 calls; one helpline answered 
31 to 60 calls and two helplines answered 61 
or more calls. The Drugs/HIV Helpline in Ireland 
answered an average of 16 calls per day, though 
this figure included calls about sexual health. 
There were 2,125 calls between January and 
July 2006 which represents a 6% decrease when 
compared to the preceding six-month period 
(Aileen Dooley, personal communication, 2007). 
The FESAT report notes a continuation of the 
upward trend in the numbers of calls about 
cocaine (8 helplines) and about alcohol (6 
helplines) across Europe. There were increases 
also in the numbers of calls about cannabis and 
ecstasy. There were decreases in the numbers 
of calls about injecting heroin and magic 
mushrooms. 
In Ireland, there was some decrease in the 
number of calls to the Drugs/HIV Helpline about 
cocaine, from 257 in the second half of 2005 
to 226 in the first half of 2006. The number of 
calls about alcohol remained unchanged at an 
average of 235 calls for each reporting period. 
There was some decrease in the number of calls 
about cannabis, and a large decrease in the 
number of calls about magic mushrooms in the 
first half of 2006 when compared to the second 
half of 2005. There was some increase in calls 
about ecstasy in the first half of 2006. (Aileen 
Dooley, personal communication, 2007)
During the first half of 2006, three helplines in 
Europe received calls about drugs that had not 
been reported to them before. A helpline in 
Greece reported a call about a substance called 
‘Mothball’ but did not describe its appearance 
or its effect. The helpline in the Netherlands 
reported calls about two new drugs, Original 
69 and Ethyltryptamine. Original 69 is a blue 
liquid (containing MDMA and amphetamine) 
presented in 25 ml bottles and usually sold to 
people attending parties; this liquid has a similar 
effect to ecstasy. Ethyltryptamine is a pill which 
has hallucinogenic effects. The Norwegian 
helpline reported calls about methamphetamine 
and Ayahuasca. Methamphetamine has been 
reported by helplines in other countries. 
Ayahuasca is a tea made from plants; its use may 
result in neurotic or psychotic episodes. The 
Drugs/HIV Helpline in Ireland did not report calls 
about any new drugs.
(Jean Long)
1.  Hibell B (2007) FESAT Monitoring Project 
 – Changes during the first half of 2006. 
Brussels: FESAT (The European Foundation of 
Drug Helplines). 
More information about FESAT can be found on 
the website of the European Foundation of Drug 
Helplines at www.fesat.org 
The Drugs/HIV Helpline in Ireland is a 
confidential, freephone, active listening 
service offering non-directive support, 
information, guidance and referral 
to anyone with a question related to 
substance use or HIV and sexual health. 
Set up in July 1997, the service is funded 
and managed by the Health Service 
Executive. 
The freephone number is 1800 459 459. 
The Helpline manager is Aileen Dooley.
Identifying new drugs and new 
drug trends with the help of  
drug helplines
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Update on direct drug-related deaths 
in Ireland 
Problem drug use can lead to premature death. 
Deaths can occur as a result of overdose (both 
intentional and unintentional), actions taken under 
the influence of drugs, medical consequences and 
incidental causes. Drug-related deaths and mortality 
among drug users are indicators of the consequences 
of problem drug use in Ireland. 
The data presented in this article provide the number 
of direct drug-related deaths between 1980 and 
2004, based on unpublished data from the Central 
Statistics Office (CSO). Direct drug-related deaths 
are those occurring as a result of overdose. At the 
European level, the European Monitoring Centre 
for Drugs and Drug Addiction (EMCDDA) has 
developed a standardised method for extracting data 
on drug-related deaths from the mortality registers 
in all member states.1 Staff at the CSO 2 extracted 
and collated the data in February 2007, using the 
EMCDDA’s ‘Selection B’ definition of drug-related 
death. 
Figure 1 presents the numbers of direct drug-related 
deaths in Ireland between 1980 and 2004, extracted 
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Figure 1   Number of direct drug-related deaths in Ireland reported by the CSO, 1980 to 2004 (unpublished data 
from the vital statistics)
On 24 February 2007 the combination drug Suboxone1 
was launched in Ireland. The Department of Health 
has established an expert group to consider the 
implications of the introduction of this drug and its use 
as a treatment for opiate dependency. In order for this 
drug to be prescribed, a system similar to that existing 
for methadone, including a protocol and a central 
register, will be required. 
Made by Schering Plough, Suboxone is taken by 
placing the pill under the tongue and allowing it to 
dissolve. The product contains two active ingredients 
– buprenorphine, a partial opiate agonist, which helps 
manage the cravings associated with opiate withdrawal, 
and naloxone, an opiate antagonist, which prevents 
overdose if the drug is injected. Suboxone tablets are 
available in two strengths (containing either 2 mg or 8 
mg of buprenorphine). The naloxone content is one-
quarter that of the buprenorphine content. This drug is 
taken daily. Since Suboxone is eliminated through the 
liver, the dosage needs to be lowered for people with 
mild or moderate liver dysfunction. This drug is not 
recommended for people with severe liver dysfunction. 
According to the producers, Suboxone should not be 
used during pregnancy. If a woman becomes pregnant 
while on Suboxone treatment, she should be changed 
to another opiate substitute. The respiratory depressant 
effect of Suboxone is amplified when the drug is 
consumed with alcohol or benzodiazepines. 
The introduction of Suboxone to Ireland provides 
another choice of treatment for problem opiate use, as 
well as an opportunity to identify which substitute is 
most suitable for different sub-groups of patients.
(Jean Long)
1.  European Medicines Agency (2006) Suboxone: 
Summary of product characteristics. Retrieved April 
2007 from www.emea.eu.int/humandocs/PDFs/
EPAR/suboxone/H-697-PI-en.pdf
Suboxone licensed in Europe
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from the General Mortality Register. There were 
few such deaths in the 1980s. Between 1990 
and 1994, there was a small but steady increase 
in the number of drug-related deaths, and 
between 1995 and 1999 a substantial increase. 
This was followed by a considerable decline in 
the number of deaths between 2000 and 2002. 
In 2003, the number of drug-related deaths 
increased marginally when compared to 2001 
and 2002, with a further increase in 2004. 
Between 2001 and 2004, 60% of direct drug-
related deaths were opiate-related. In 2000 
two (1.8%) drug-related deaths were due to 
cocaine alone; this increased to nine (8%) in 
2004. The coding system used does not allow 
one to extract data on cocaine and other 
drugs combined, therefore these figures are an 
underestimate of cocaine-related deaths.
Figure 2 presents the numbers of direct drug-
related deaths in Dublin and in the rest of 
Ireland between 1980 and 2004. 
According to data from the General Mortality 
Register, almost all direct drug-related deaths 
between 1980 and 1994 occurred in Dublin. 
Between 1995 and 1999, there was a substantial 
increase in such deaths in Dublin, from 33 to 96, 
and a steady increase outside the Dublin area, 
from 3 to 26. 
Between 2000 and 2003, there was a sharp 
decline in direct drug-related deaths in Dublin, 
from 83 to 46. Between 2003 and 2004, there 
was a considerable increase, from 46 to 60 
drug-related deaths. This is the first year such an 
increase has been reported in Ireland since 1999. 
This trend has been reported in other European 
countries. Factors contributing to this trend may 
include, in addition to the increase in cocaine-
related deaths mentioned above, the ageing 
population among drug users and an increase in 
both the availability and purity of heroin reported 
in Europe generally.
During the period 2000 to 2004, there was 
a continued increase in drug-related deaths 
outside Dublin, from 30 in 2000 to 52 in 2004. 
In 2003, the number of such deaths outside 
Dublin exceeded for the first time the number 
in Dublin; however, the trend reversed in 2004, 
with more drug-related deaths reported in 
Dublin than outside Dublin. The data for outside 
Dublin follow trends in problem opiate use in 
that geographical area. 
(Ena Lynn, Jean Long and Lorraine Coleman) 
1.  EMCDDA (2002) The DRD-Standard, version 
3.0: EMCDDA standard protocol for the EU 
Member States to collect data and report figures 
for the key indicator drug-related deaths by 
the standard Reitox tables. EMCDDA project 
CT.02.P1.05. Lisbon: European Monitoring 
Centre for Drugs and Drug Addiction. 
2.  The authors would like to thank Joseph 
Keating at the Central Statistics Office for 
extracting and collating the data on direct 
drug-related deaths from the General 
Mortality Register. 
Update on drug-related deaths (continued)
Figure 2   Number of direct drug-related deaths in Ireland, by plac of death, reported by the CSO, 
1980 to 2004 (unpublished data from the vital statistics)
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The fifth annual report from the National Registry 
of Deliberate Self Harm was published in March 
2007. The report contains information relating to 
each episode of deliberate self-harm from persons 
presenting to all general hospital A&E departments 
and two of the three paediatric hospital A&E 
departments in Ireland in 2005. The Registry 
defines deliberate self-harm as ‘an act with non-fatal 
outcome in which an individual deliberately initiates 
a non-habitual behaviour, that without intervention 
from others will cause self-harm, or deliberately 
ingests a substance in excess of the prescribed or 
generally recognised therapeutic dosage, and which 
is aimed at realising changes that the person desires 
via the actual or physical consequences’.1 
The report concludes that there were 10,789 
presentations of deliberate self-harm, involving 
8,594 individuals, to hospital A&E departments 
in 2005. The number of presentations was 3% 
lower than in 2004, when there were 11,092 
presentations by 8,610 individuals. The age-
standardised rate of deliberate self-harm was 198 
per 100,000, compared with 201 per 100,000 in 
2004, representing a 2% decrease. The national 
rate in 2005 was 37% higher among females 
than among males, at 230 per 100,000 and 167 
per 100,000 respectively. Forty-six per cent of all 
presentations were by persons less than 30 years 
of age, and 87% by persons less than 50 years of 
age. The peak age range for females presenting 
was 15–19 years, at 606 per 100,000. The peak 
age range for males presenting was 20–24 years, 
at 392 per 100,000. There was evidence of alcohol 
consumption in 41% of all episodes of deliberate 
self-harm. 
Drug overdose was the most common form of 
deliberate self-harm, representing 76% of all such 
episodes (7,751 episodes). Overdose rates were 
higher among females (82%) than among males 
(67%). On average, 31 tablets were taken in 
episodes of drug overdose. The total number of 
tablets taken was known in 80% of cases. Forty-one 
per cent of all drug overdoses involved a minor 
tranquilliser, 32% involved paracetamol and 23% 
involved anti-depressants. 
Self-cutting was the second most common method 
of deliberate self-harm, representing 21% of all 
episodes. In contrast to drug overdoses, self-cutting 
was more common among males than among 
females. 
Repetition of deliberate self-harm accounted for 
20.5% of all presentations in 2005. Cutting and 
attempted hanging were methods of self-harm 
associated with an increased level of repetition. 
The report recommends the following measures to 
reduce the incidence of deliberate self-harm:
a comprehensive mental health awareness 
campaign to reduce levels of psychiatric and 
psychological morbidity in the population
additional resources to support mental health 
promotion, and specialist mental health 
services for adolescents aged 15–19 years
evidence-based interventions targeting persons 
who repeatedly self-harm 
a mechanism for linking data collected by 
the Registry with data on suicide mortality 
to improve understanding of the relationship 
between deliberate self-harm and the risk of 
suicide in the future
extension of the core Registry dataset to 
support evaluation of progress on actions in 
the strategy document on suicide prevention, 
Reach Out.2
(Lorraine Coleman and Ena Lynn)
1.  National Registry of Deliberate Self Harm Ireland 
(2007) Annual Report 2005. Cork: National 
Suicide Research Foundation. 
2.  HSE, National Suicide Review Group and 
Department of Health and Children (2005) 
Reach Out: National Strategy for Action on Suicide 
Prevention 2005–2014. Dublin: Health Service 
Executive.
■
■
■
■
■
National Registry of Deliberate 
Self Harm – annual report 00
Drug overdose 
was the most 
common form 
of deliberate 
self-harm, 
representing 
76% of all such 
episodes (7,751 
episodes). 
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Anyone with access to the Internet can now 
find out at the click of a mouse who’s doing 
what in problem alcohol and drug use research 
in Ireland. The National Documentation Centre 
on Drug Use (NDC) is compiling an online 
register of current research and evaluation 
(CRED) in the area of drug use, problem alcohol 
use and related fields in Ireland.  The NDC is 
also compiling a Directory of Researchers and 
Evaluators currently conducting research in these 
fields. 
NDC staff identify research projects by 
contacting all major research and evaluation 
institutions, researchers and evaluators in the 
field of drug misuse, and by searching relevant 
websites. The CRED database records the title of 
each project, its aims, the research or evaluation 
methods used, the names of commissioning 
bodies, funding details and the names of the 
researchers and evaluators involved in the 
project. The database only includes details 
of current projects. Completed projects will 
be placed in an archive and will no longer be 
publicly displayed. The aim of CRED is to provide 
a comprehensive overview of ongoing research 
in the area of alcohol and drug use. 
CRED is an important tool for researchers and 
evaluators as it can help:
increase awareness of the work they are 
doing among a wide audience
identify individuals working in areas of 
mutual interest
find other similar projects and minimise 
duplication of effort 
streamline the search for relevant information 
identify potential funders and commissioning 
bodies.
Once a contributor registers with this service 
they can submit their own projects, update them 
and edit their profiles at their ease. This database 
is a growing resource and we will continue to 
add new or existing projects as we receive them. 
We welcome on-line submissions of suitable 
material for inclusion in this database. Please 
contact mnelson@hrb.ie for further information, 
or visit our website at www.ndc.hrb.ie 
(Mairea Nelson)
■
■
■
■
■
Find out who’s doing what in 
alcohol and drug research
Eoin Ryan MEP launched Now & Next, the Ana 
Liffey Drug Project strategic plan for the next five 
years on 15 June 2007. 
Now & Next: ADLP strategic plan 2007–2011 can 
be downloaded from the Resources page of the 
Ana Liffey website at www.aldp.ie.
Ana Liffey strategic plan  
007–011
From left: Eoin Ryan MEP and Tony Duffin, 
director of the Ana Liffey Drug Project, at the 
launch of Now & Next (Photo: Jim Berkeley)
On 8 February 2007 benzylpiperazine (BZP) was the 
subject of a written answer in Dáil Éireann from the 
Minister for Health and Children, Mary Harney TD: ‘A 
risk assessment is being carried out at EU level on BZP. 
This engages the relevant experts across the EU to assess 
the possible health and social risks/consequences of the 
identified substance and the implications of placing it 
under control. The results of the risk assessment will be 
presented to the Council, the European Medicines Agency 
and the Commission for a decision on whether BZP should 
be subjected to control measures. Control measures and 
penalties are decided according to national laws which in 
turn comply with UN conventions.’ www.oireachtas.ie 
On 7 March 2007 the Irish Society for the Prevention of 
Cruelty to Children (ISPCC) published its Childline Annual 
Call Statistics for 2006. Among its telephone calls, 1,993 
(1.55%) were in regard to child substance use and abuse. 
Among contacts via the website, three (1.42%) were about 
child substance use and abuse. www.ispcc.ie 
On 15 March 2007 Ana Liffey Drug Project, Ireland’s first 
harm reduction agency, celebrated its 25th anniversary, 
with a half-day conference. www.aldp.ie 
On 27 March 2007 the Joint Committee on Arts, Sports, 
Tourism, Community, Rural and Gaeltacht Affairs 
released its 12th and 13th reports. Drug abuse in Ireland 
– a Waterford perspective finds that the majority of people 
seeking help for addiction in the Waterford constituency 
are using more than one drug, with alcohol and hash being 
by far the most popular cocktail for almost two thirds. 
A history of addiction in the family is overwhelmingly 
prevalent. The relationship between alcohol misuse and 
the drinks industry sponsorship of sporting activities 
explores the links between sponsorship of sports by alcohol 
companies and the risk to people, especially young people, 
through misuse of alcohol. The report attempts to assess 
the effectiveness of a ban on such sponsorship and explores 
the related issues. www.oireachtas.ie
In March 2007 the International Drug Policy Consortium 
(IDPC) released its 4th briefing paper, The European Union 
Drug Strategy: progress and problems. Despite progress, 
the briefing reports that current evaluation data suggest 
that drug use in Europe is only being contained at best 
and, despite several successes in reducing the harmful 
consequences, problems such as drug-related crime, drug-
related deaths, and rates of hepatitis infection among drug 
injectors remain unacceptably high. The IDPC suggest 
ways in which the current EU strategy and actions could be 
strengthened. www.internationaldrugpolicy.net 
In March 2007 the RSA Commission on Illegal Drugs, 
Communities and Public Policy published a report on 
its two-year study of UK drug policy. It calls for a radical 
rethink of drugs policy, drawing it away from criminal 
justice and refocusing it on health and social support. 
Claiming that the Misuse of Drugs Act 1971 is ‘no longer 
fit for purpose’, the Commission calls for a new Misuse of 
Substances Act, to include alcohol, tobacco, solvents, and 
over-the-counter and prescription drugs.  
www.rsadrugscommission.org 
On 5 April 2007 Barnardos launched its Children’s 
Declaration – A million reasons to get it right. Among 
the key action points advanced in the Declaration is the 
following: ‘Given the strong connections between alcohol 
abuse and drug abuse, the National Alcohol Strategy and 
National Drugs Strategy should be reviewed with the 
view of identifying key areas where both strategies can be 
integrated to reinforce each other – both national plans are 
currently being administered separately.’ www.barnardos.ie 
On 16 April 2007 CityWide Drugs Crisis Campaign 
launched a campaign in the run-up to the general election 
entitled ‘Drugs: a new deal’. www.citywide.ie 
On 19 April 2007 the UK Drug Policy Commission 
(UKDPC) was launched along with its first report, An 
analysis of UK drug policy, by Peter Reuter and Alex 
Stevens. The UKDPC is an independent body set up 
to provide objective analysis of UK drug policy. The 
Commission aims to improve political, media and public 
understanding of drug policy issues and the options for 
achieving a rational and effective response to the problems 
caused by the supply of and demand for illegal drugs. 
www.ukdpc.org 
On 26 April 2007 Mental Health Awareness and Attitudes 
Survey January/February 2007 was launched. Suicide, 
alcoholism, depression and drug dependence are believed 
to be the most important mental health and related 
problems we need to tackle in Ireland. www.nosp.ie 
On 27 April 2007 Merchants Quay Ireland hosted a pre-
election debate on drugs issues in Ireland, entitled ‘Drugs: 
the politicians’ prescription’. www.mqi.ie 
In April 2007 the Irish College of General Practitioners 
(ICGP) announced that its Methadone GP Co-ordinator, 
Dr Ide Delargy, is extending her services to GPs outside the 
former ERHA area. She will act as a resource for GPs already 
involved in prescribing methadone under the protocol, and 
will aim to increase the number of GPs participating in the 
protocol throughout the country. GPs can reach Dr Delargy 
on 01-230-2659 or 086-810-0803 or at iddelargy@eircom.
net www.icgp.ie 
In April 2007 ENCOD (European Coalition for Just and 
Effective Drug Policies) released its 2006 annual report. 
In 2007 ENCOD has set itself the challenge of obtaining 
a meaningful and transparent dialogue with authorities 
of the European Union; it reports that the European 
Commission has promised to initiate a dialogue process 
with civil society concerning drug policies in the second 
half of the year. Additionally, ENCOD will co-ordinate the 
preparation of the campaign for the UN meeting in March 
2008 in Vienna. www.encod.org 
(Compiled by Brigid Pike)
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Broader remit for EMCDDA 
Cited from Drugnet Europe No. 57,  
January–March 2007
The revised EMCDDA regulation [EC Regulation No. 
1920/2006] adopted by the European Parliament 
and the council of the EU … broadens the scope of 
the Centre’s tasks, granting it a more active role in 
monitoring new methods of drug use and related trends. 
Specifically, it allows the agency to collect, register and 
analyse information on ‘emerging trends in polydrug 
use’, including the combined use of licit and illicit 
psychoactive substances. 
A key aspect of the new remit is providing information 
on best practice in the EU Member States and facilitating 
exchange of such practice between them. …the EMCDDA 
may also be called on to transfer its know-how to certain 
non-EU countries, such as official candidates for EU 
accession and countries in the Western Balkans. This is 
likely to entail creating and reinforcing links with the Reitox 
network and assisting in the building and strengthening of 
national focal points. 
The Centre’s own administration is also being 
overhauled, with the Management Board (on which all 
Member States and other stakeholders are represented) 
to be assisted by a new six-member Executive Committee 
to prepare the decisions of the Board and to advise the 
Director. …the existing Scientific Committee is being 
slimmed down to a maximum of 15 members to be 
chosen through a public selection process based on 
scientific excellence and independence.
From Drugnet Europe
No. 15: Hallucinogenic mushrooms: the challenge of 
responding to naturally occurring substances in an 
electronic age
This policy briefing, No 15 in the Drugs in focus series 
issued by the EMCDDA, reviews information on the 
use of hallucinogenic mushrooms in Europe and draws 
lessons to inform policy. 
Naturally occurring hallucinogens can be found 
in over 100 species of mushroom, most of which 
contain psilocybin and psilocin as the main ingredients 
responsible for the hallucinogenic effect. These 
ingredients are controlled at the highest level 
internationally, but there is a lack of legal clarity in 
some countries with regard to mushrooms containing 
these substances. This confusion has been exploited by 
mushroom retailers and has presented obstacles to the 
development of mechanisms to control supply.
Among the key points made in this briefing are:
Among young people aged 15 to 24 years in 12 
EU Member States, the proportion who have ever 
used hallucinogenic mushrooms ranges from less 
than 1% to 8%. Their use is more common among 
young people who have used other illegal drugs than 
among young people who have not.
The sale of hallucinogenic mushrooms by ‘smart’ 
shops and market stalls in the Netherlands and the 
UK appears to have played an important role in 
facilitating their use.
A recent internet search identified 39 online shops 
that sell hallucinogenic mushroom products. 
Considerable variation was noted in the extent and 
quality of information provided about the health risks 
of the products sold.
■
■
■
The reported number of fatal and non-fatal 
emergencies from hallucinogenic mushroom use 
is very low. In general, the physiological effects are 
short-lasting and not significant; it is more commonly 
linked to mental health risks and, in a significant 
number of cases, to panic attacks.
The unpredictable effects of these mushrooms, and 
social constraints on young experimenters, may act as 
barriers to regular or frequent use.
Six EU countries, including Ireland, have tightened 
their legislation on mushrooms since 2001 in 
response to concerns about the prevalence of use. 
There are signs that online retailers have responded 
by switching to uncontrolled and, in some cases, 
more toxic alternatives.
There appears to be a gap in the provision of 
mushroom-specific information material for 
professionals working with young people and a 
similar lack of prevention or harm reduction material 
aimed at potential users.
Drugs in focus is a series of policy briefings published 
by the European Monitoring Centre for Drugs and 
Drug Addiction (EMCDDA). The briefings  
are available on the EMCDDA website at  
www.emcdda.europa.eu
If you would like to receive a hard copy of the 
current or future issues of Drugs in focus, please 
contact: Alcohol and Drug Research Unit,  
Health Research Board, Knockmaun House,  
42–47 Lower Mount Street, Dublin 2.
Tel: 01 2345 127
Email: adru@hrb.ie
■
■
■
■
Drugs in focus – policy briefing
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Progress review — EU drugs action plan 
(2005–2008) 
Cited from Frank Zobel Drugnet Europe  
No. 57, January–March 2007
The European Commission released on 21 
December the first progress review on the 
implementation of the EU drugs action plan 
(2005–2008) [SEC(2006) 1803]. Covering the 
18-month period from the plan’s adoption on 
27 June 2005 to December 2006, the report 
assesses to what extent activities foreseen for 
this period have been implemented and their 
objectives reached.
In the report’s conclusions, issues outlined as 
requiring closer attention include: a better 
coordination between public health and law-
enforcement bodies at all levels; more realistic 
and feasible indicators for some actions; and 
the involvement of civil society in forthcoming 
reviews in the context of the Commission’s 
‘Green Paper on the role of civil society in drugs 
policy in the European Union’.
EMCDDA strategy and work programme 
(2007–2009): A sound framework for drugs 
monitoring in Europe
Cited from Drugnet Europe No. 57, January–
March 2007
Working more efficiently, investing more in 
analysis and communicating more effectively 
with key audiences are among the goals of the 
EMCDDA’s new work programme (2007–2009). 
Adopted by the Management Board in 2006, the 
programme charts the agency’s direction and 
activities for the next three years. Its underlying 
strategy is straightforward: to concentrate on 
the EMCDDA’s core business of monitoring the 
drugs phenomenon and to ensure that full value 
is secured from the investments made in this 
area. Its guiding principles are a commitment 
to scientific excellence, partnership, good 
governance and efficiency.
For more on the 2007–2009 work programme, 
see www.emcdda.europa.eu/?nnodeid=25311
BZP under formal scrutiny
Cited from Roumen Sedefov Drugnet Europe  
No. 58, April–June 2007
Europe has responded to rising concern over 
the use of the stimulant drug BZP by formally 
requesting an investigation into the health 
and social risks of the substance. …The risk-
assessment exercise, which will result in a 
report by mid-June, will be undertaken by 
the EMCDDA’s Scientific Committee, with 
participation of additional experts from the 
European Commission, Europol and the 
European Medicines Agency (EMEA). The 
exercise is part of a three-step procedure: 
information exchange, risk assessment and 
decision-making.
New project to improve TDI data coverage
Cited from Linda Montanari Drugnet Europe  
No. 58, April–June 2007 
Assessing and improving data coverage in 
the area of treatment demand is the aim of a 
new EMCDDA project launched in April 2007. 
Oriented by proposals from an expert group 
meeting in February, the project will be carried 
out in eight volunteer countries and is scheduled 
for completion by summer. The results will be 
presented in September at the EMCDDA’s annual 
treatment demand expert meeting in Lisbon.
Commission launches report on harm 
reduction in the EU
Cited from Dagmar Hedrich Drugnet Europe  
No. 58, April–June 2007
The European Commission launched a report in 
April on the prevention and reduction of health-
related harm associated with drug dependence 
in the EU [COM(2007) 199 final]. The report 
assesses to what extent Member States have 
implemented a 2003 Council recommendation 
which aimed to reduce drug-related deaths and 
health damage by encouraging countries to 
develop specific services and facilities.
In its conclusions, the Commission report states 
that all Member States have now installed 
policies and actions reflecting proposals set out 
in the 2003 recommendation, but the level 
of implementation varies within and between 
countries. And while high-quality data exist on 
the availability of harm-reduction services, data 
on their accessibility and utilisation, especially by 
high-risk groups, should be improved.
 
Drugnet Europe is the quarterly newsletter 
of the European Monitoring Centre for 
Drugs and Drug Addiction (EMCDDA). 
An electronic version of Drugnet Europe is 
available on the EMCDDA website at www.
emcdda.europa.eu
If you would like to receive a hard copy 
of the current or future issues of Drugnet 
Europe, please contact: Alcohol and Drug 
Research Unit, Health Research Board, 
Knockmaun House, 42–47 Lower Mount 
Street, Dublin 2; Tel: 01 2345 127; Email: 
adru@hrb.ie
From Drugnet Europe (continued)
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Books
Using evidence: how research can inform 
public services
Nutley M, Walter I and Davies H
The Policy Press 2007, 363 pp.
ISBN 978 1 86134 664 3
This book examines the ways in which research 
can influence debate, policy choices and practice 
arrangements, how such influence is mediated, 
blocked or amplified, and how its impact might 
be enhanced. The authors discuss what we know 
about the influence of research on national and 
local policy actors and front-line practitioners, 
believing that the ways in which research is 
combined with other forms of evidence and 
knowledge could have important impacts on the 
nature, distribution, effectiveness, efficiency and 
quality of public services. They take particular 
care to locate their interest in ‘research use’ as 
being more wide-ranging than the often limited 
scope inferred by the expression ‘evidence-based 
policy and practice’. The book draws on studies 
of ‘research use’ in four key public service areas: 
health care, social care, education and criminal 
justice. 
The first chapter introduces the issues in the 
historical context of the evidence-based policy 
and practice agenda. The next three chapters 
attempt to answer the questions: What is 
research use? What shapes its uptake? How has 
research use been modelled? Further chapters 
lead to a synthesis of what this understanding 
can mean for increasing or influencing research 
use in the field. These chapters discuss the 
evidence of the effectiveness of different 
mechanisms for promoting the use of research, 
what we can learn from the literature on 
learning and knowledge management, and 
what strategies for improving research use are 
available and likely to be effective. The final two 
chapters address the challenges facing those 
who seek to assess the wider impacts of social 
research, and draw some conclusions from the 
linking arguments presented throughout the 
book.
Multi-component programmes: an approach 
to prevent and reduce alcohol-related harm
Thom B and Bayley M
Joseph Rowntree Foundation 2007, 82 pp.
ISBN 978 1 85935 549 7  
(PDF available at www.jrf.org.uk)
A key part of UK national strategy on reducing 
alcohol-related harm is a focus on local 
responsibility for policy implementation and an 
expectation that stakeholders – local authorities, 
professional groups, the alcohol trade and 
‘communities’ – will work together in addressing 
the problems.
This report reviews international experience 
of community-based prevention programmes 
to address alcohol-related harms at local level. 
It describes a ‘multi-component’ model, with 
evidence from programmes in the USA, Australia, 
New Zealand and Scandinavia. The approach 
typically requires a programme of multiple, 
co-ordinated initiatives rather than ‘stand-alone’ 
projects, and an emphasis on encouraging 
change in local policies, structures, systems 
and drinking cultures. The involvement of local 
communities is central to most programmes. 
The report reveals problems in implementing 
and sustaining this approach as well as the 
advantages it offers. Discussions with a small 
group of professionals showed widespread use 
of ‘partnership’ approaches and suggested that 
the use of a more explicit multi-component 
model would be helpful to map alcohol-related 
problems and design local strategies.
The introductory chapter gives the background 
and rationale for multi-component programmes 
and sets out the authors’ aims and the methods 
used. Chapter 2 provides an overview of the 
identified programmes, their aims, structures 
and components. The third chapter discusses 
evaluation and considers whether these 
programmes ‘work’ or are more likely to succeed 
than stand-alone projects. Chapter 4 introduces 
two main theoretical frameworks that inform 
the development and implementation of 
many multi-component programmes. Chapter 
5 considers some key issues influencing the 
development of multi-component approaches, 
and a brief Endnote sums up the potential for 
such approaches to make a contribution in the 
UK context, taking account of the influence of 
national policies on local action. Details of the 
multi-component programmes identified, a table 
summarising reported programme evaluations 
and a list of publications consulted are given in 
three appendices.
Policing cannabis as a Class C drug: an 
arresting change?
May T, Duffy M, Warburton H and Hough M
Joseph Rowntree Foundation 2007, 55 pp.
ISBN 978 1 85935 543 5  
(PDF available at www.jrf.org.uk)
In the UK in January 2004, cannabis was 
reclassified from a Class B to a Class C drug. 
This report, by the Institute for Criminal Policy 
Research at King’s College London, describes 
the impact of reclassification on the policing 
of cannabis possession. To date, little research 
has been carried out in this area and there is a 
lack of knowledge about how reclassification 
Recent publications
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has affected policing practice. The study 
reported here largely replicates a study of 
cannabis policing that was carried out before 
reclassification (May et al. 2002). For this 
report, researchers returned to the same sites, 
where they observed patrol officers at work, 
interviewed officers and young people, analysed 
custody records and street warning statistics, 
and mounted an internet survey on people’s 
knowledge about, and attitudes towards, the 
cannabis laws.
The study describes how the legislative changes 
and associated guidelines have been put into 
practice and provides a snapshot view of the 
impact of these changes. It describes the new 
procedures and documents current practice in 
relation to arrests for ‘aggravated possession’ 
and warnings issued on the street (particularly 
for repeat offenders). The report also assesses the 
impact on police resources, explores police views 
about the changes and examines young people’s 
knowledge and attitudes about the changes. 
The authors conclude that if cannabis policing 
is to be seen as equitable and fair and the 
criminal justice system as open and transparent, 
the policing of cannabis needs to be non-
discriminatory, adequately monitored and 
critically evaluated at regular intervals.
Journal articles
The following abstracts are cited from 
recently published articles relating to the 
drugs situation in Ireland.
Nalbuphine (Nubain): Non-prescribed use, 
injecting, and risk behaviors for bloodborne 
viruses 
McElrath K and Connolly D
Contemporary Drug Problems 2006; 33(2): 
321–340
Nalbuphine hydrochloride is a synthetic 
opiate with agonist-antagonist properties that 
has been prescribed for pain relief in several 
countries in North and Central America, Europe 
and elsewhere. Marketed for several years 
under the trade name Nubain, the drug was 
believed to have low potential for dependence. 
Research into nalbuphine misuse is limited 
but studies have documented misuse among 
some bodybuilders, weightlifters, and users of 
anabolic steroids. This study examines patterns 
of nalbuphine misuse and injecting behaviours 
that pose risk for blood-borne viruses among 10 
respondents residing largely in one community 
in Ireland. Contrary to other research findings, 
most individuals had no history of weightlifting 
and no experience with the use of anabolic 
steroids. Most of the respondents had injected 
nalbuphine several times per day, and reported 
frequent injection of stimulants. Respondents 
reported that needles and syringes were scarce. 
At least some of the nalbuphine in the region 
has been found to be ‘counterfeit’. Implications 
of the findings are discussed.
Challenging times: prevalence of psychiatric 
disorders and suicidal behaviours in Irish 
adolescents
Lynch F, Mills C, Daly I and Fitzpatrick C
Journal of Adolescence 2006; 29(4):555–73
Against a background of a lack of systematic 
epidemiological research in the area in Ireland, 
this study set out to determine prevalence 
rates of psychiatric disorders, suicidal ideation 
and intent, and parasuicide in a population 
of Irish adolescents aged 12–15 years in a 
defined geographical area. All 12–15-year olds 
attending eight secondary schools were eligible 
for inclusion. A two-stage procedure involving 
a screening and an interview phase was used. 
Those scoring in the clinical range on the 
screening measures were interviewed, along 
with a comparison group matched for gender, 
school and school year. Of the 723 adolescents 
screened, 19.4% were identified as being ‘at 
risk’. This ‘at risk’ group was interviewed along 
with a comparison sample. Of the total study 
population, 15.6% met the criteria for a current 
psychiatric disorder, including 4.5% with an 
affective disorder, 3.7% with an anxiety disorder 
and 3.7% with ADHD. Significant past suicidal 
ideation was experienced by 1.9%, and 1.5% 
had a history of parasuicide. Binge drinking was 
associated with both affective and behaviour 
disorders. The authors conclude that rates of 
psychiatric disorders and suicidal behaviours in 
young Irish adolescents are similar to those in 
other Western cultures and that mental health 
promotion should be given priority in schools.
Factors affecting the outcome of methadone 
maintenance treatment in opiate dependence
Kamal F, Flavin S, Campbell F, Fagan J, Behan C 
and Smyth R
Irish Medical Journal 2007; 100(3):393–7
This study aimed to measure the rates of 
ongoing heroin abuse among patients on 
methadone maintenance treatment (MMT) and 
to identify patient and treatment characteristics 
associated with poorer outcome. The study was 
carried out at an outpatient drug treatment clinic 
and included all patients who were on MMT 
during a three-month period in 2004. Treatment 
response was measured by analysis of opiate-
positive urine samples. Of the 440 patients, 63% 
were male and their mean age was 32 years 
(range 17 to 52 years); 163 patients (37%) had 
a co-existing psychiatric illness. The average 
methadone dose was 74mg. On average, 71% 
Recent publications (continued)
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of urine samples were opiate-negative. Shorter 
time in treatment (less than 24 months), 
lower dose of methadone, cocaine abuse and 
intermittent benzodiazepine abuse were each 
found to be significantly associated with lower 
rates of opiate abstinence. Outcomes were 
not associated with gender, age or receipt of 
counselling. Dual-diagnosed patients tended to 
have higher rates of abstinence (p=0.08). MMT 
clients who abuse cocaine and benzodiazepines 
are at increased risk of continuing opiate abuse. 
Higher doses of methadone might be necessary 
to prevent illicit opiate abuse.
Epidemiology of hepatitis C infection, ERHA/
HSE Eastern Region
O’Meara M, Barry J and Mullen L
Irish Medical Journal 2007; 100(2):365–6
Hepatitis C became statutorily notifiable 
in Ireland on 1 January 2004. Prior to 
2004, only hepatitis A and hepatitis B were 
notifiable as distinct types of hepatitis. A 
third category, notifiable under the Infectious 
Diseases Regulations 1981, was ‘viral hepatitis 
unspecified’. The majority of cases notified under 
this heading were thought to be due to infection 
with hepatitis C virus (HCV). Between 1 January 
2004 and 31 December 2005, the Department 
of Public Health HSE Eastern Region, received 
notification of 2,014 cases of HCV infection 
(2004, 941 cases; 2005 1,073 cases). This report 
outlines basic demographic details on cases 
notified, and comments on missing data. Peak 
age band at notification for males and females 
was in the 25-29 year old age group where 
538 (26.7%) were notified. Thirty cases notified 
(1.5%) were under 15 years of age. Drug misuse 
has been confirmed as a risk factor for 1,247 
(61.9%) of cases notified, and may be a risk 
factor in a large percentage of the reminder, 
where risk factor data are unknown. Problems 
with completeness of notification have been 
identified. Enhanced surveillance of all hepatitis 
C infections is a prerequisite for future service 
planning.
Alcohol dependence and mood state in a 
population receiving methadone maintenance 
treatment
MacManus E and Fitzpatrick C
Irish Journal of Psychological Medicine 2007; 
24(1): 19–22
The aim of this study was to assess the 
prevalence of alcohol dependence and anxiety 
and depressive disorder symptomatology 
among heroin users in drug treatment. Fifty-five 
clients on methadone maintenance treatment 
programmes in Dublin were interviewed. 
Prevalence rates were found to be 56% [n=31] 
for alcohol dependence, 56% [n=31] for 
anxiety disorder symptomatology, and 42% 
[n=23] for depressive order symptomatology. 
This finding of comorbid alcohol dependence 
and psychopathology among methadone 
maintenance treatment clients suggests 
that both clients’ health and methadone 
maintenance treatment participation and 
completion rates may be compromised. The 
author concludes that alcohol dependency 
and psychopathology among methadone 
maintenance treatment clients should be 
considered when providing effectively targeted 
services to the drug-using population.
Management of hepatitis C among drug users 
attending general practice in Ireland: baseline 
data from the Dublin area hepatitis C in 
general practice initiative
Cullen W, Stanley J, Langton D, Kelly Y and Bury G
European Journal of General Practice 2007; 
13(1):5–12
In Ireland, general practice is increasingly 
providing long-term care for injecting drug users, 
62%–81% of whom are infected with hepatitis 
C (HCV). Clinical guidelines for the management 
of HCV among drug users have recently been 
developed in Ireland, and this study aimed to 
describe HCV care among drug users attending 
general practice in the greater Dublin area, prior 
to the implementation of the clinical practice 
guidelines. The clinical records of 196 patients 
attending 25 general practices in the Eastern 
Regional Health Authority area for methadone 
maintenance treatment were examined on site 
and anonymized data collected on HCV care 
processes. Patients had been attending general 
practice for methadone maintenance treatment 
for a mean of 30.7 months; 72% were male and 
51% had tested positive for metabolites of drugs 
of abuse other than methadone in the previous 
three months. There was evidence that 77%, 69% 
and 60% had been screened for HCV, human 
immunodeficiency virus (HIV) and hepatitis B 
(HBV), respectively. Among those who had been 
tested, the prevalence of HCV, HIV and HBV 
infection was 69%, 10% and 11%, respectively. 
Of those known to be HCV positive, 36 (35%) had 
been tested for HCV-RNA (29 testing positive), 31 
(30%) had been referred to a hepatology clinic, 
24 (23%) had attended a clinic, 13 (13%) had a 
liver biopsy performed and three (3%) had started 
treatment for HCV. While the majority of patients 
have been screened for blood-borne viruses, a 
minority of those infected with HCV have had 
subsequent investigations or treatment. New 
interventions to facilitate optimum care in this 
regard need to be considered.
(Compiled by Joan Moore and Louise Farragher)
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22–24 June 2007
ENCOD – European Coalition for Just and 
Effective Drug Policies General Assembly
Venue: Lange Lozanastraat 14,  
2018 Antwerp, Belgium 
Organised by / Contact:  
Tel: +32 (0) 3 293 0886
Email: info@encod.org  
www.encod.org 
Information: ENCOD members are invited to the 
general assembly to discuss the following topics: 
The dialogue with the European Union 
The ENCOD website 
The Vienna 2008 campaign 
The 2007–2008 work plan 
The approval of the Annual Report and the 
election of a new Steering Committee 
July
1–3 July 2007
First world conference on medication assisted 
treatment of opiate addiction
Venue: Cankarjev, Ljubljana, Slovenia
Organised by / Contact: European Opiate 
Addiction Treatment Association (EUROPAD), 
American Association for the Treatment of 
Opioid Dependance (AATOD) and South Eastern 
European Adriatic Addiction Treatment Network 
(SEEAnet).  
www.seea.net 
Information: This three-day interdisciplinary 
conference will discuss practice, drug policy 
research and evaluation in the field of medical 
assisted treatment of opiate addiction 
(substitution treatment).
5 July 2007
Economic and Social Research Council seminar. 
Life after punishment: drug use and desistance
Venue: The Council Room, Kings College 
London, Strand Campus, 151–171 Strand, 
London WC2R 2LS
Organised by / Contact: tim.mcsweeney@kcl.
ac.uk
Information: This is one in a series of seminars 
funded by the Economic and Social Research 
Council on the topic ‘life after punishment’. The 
seminars have been built around the concepts 
■
■
■
■
■
emerging from criminological ‘desistance’ 
theories. The 5 July seminar, chaired by Mike 
Hough, will focus on drug use and desistance. 
The aim of the seminar is to explore whether 
there is any overlap or contradiction between 
perspectives on desistance from offending and 
narratives on recovery from dependent patterns 
of drug use. The seminar will examine recent 
research to consider whether these paradigms 
contradict or complement each other. 
September 
20 September 2007 
28th annual EAP Conference: Drugs and 
alcohol – complying with the Safety, Health 
and Welfare at Work Act 2005
Venue: Carlton Hotel, Dublin Airport
Organised by / Contact: EAP Institute 143 
Barrack Street, Waterford, Ireland Tel: +353 (51) 
855733
Email: anita@eapinstitute.com  
www.eapinstitute.com
Information: The Safety, Health and Welfare 
at Work Act 2005 obliges employers to remove 
from their place of work employees who are 
under the influence of intoxicants (defined as 
drugs and alcohol). A finding by the Labour 
Court in 2006 that alcoholism is a disability 
will oblige employers to provide treatment 
and rehabilitation to employees. This one-day 
conference will address the following issues:
Managing drugs and alcohol at work
Trade union approach
Legal risk management
Maintaining a drug-free work place
Employee drug testing
Manager training
October
1–3 October 2007
10th International Symposium on Substance 
Abuse Treatment
Venue: Oslo, Norway
Organised by / Contact: Norwegian Institute for 
Alcohol and Drug Research (SIRUS) 
For questions about the program, contact Edle 
Ravndal: Tel: +47 22 34 04 42
E-mail: er@sirus.no 
■
■
■
■
■
■
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For questions about registration, 
accommodation, payment, etc., 
contact: Nada Halabi  
Tel: +47 22 34 04 00
E-mail: nh@sirus.no
Information: The 10th International 
Symposium on Substance Abuse 
Treatment aims to gather both 
researchers and practitioners 
within the field of substance abuse 
treatment in Europe. The theme 
for this year’s conference will be 
reforms, ideology and best practice. 
This symposium is a collaboration 
between the European Working 
Group on Drug Oriented Research 
and the European Federation of 
Therapeutic Communities. 
November
8–9 November 2007
3rd conference on local, integrated 
& participative responses to the 
issue of drugs use
Venue: Venice, Italy
Organised by / Contact:  
Thierry Charlois, project manager 
Tel: +33 (0)1 40 64 49 00 
info@democitydrug.org  
www.democitydrug.org
Information: The results of three 
years of practice-sharing between 
European cities will be presented at 
this, our third conference. Elected 
officials, social and health workers, 
peers, volunteers, police officers, 
judges and community members 
will work together on the evolution 
of drug-related problems. At round-
table sessions, translated into Italian, 
English and French, delegates 
will discuss the limits faced by 
partnerships as well as the innovative 
practices overcoming these obstacles. 
14 November 2007 
Writing for Publication in Addiction 
Journals
Venue: Park Inn Hotel, York, UK
Organised by / Contact: Society 
for the Study of Addiction and the 
International Society of Addiction 
Journal Editors. For more details 
and application forms, see the SSA 
website: www.addiction-ssa.org
Information: Want to improve 
your chances of getting your 
research published in peer-reviewed 
journals? You are invited to a 
one-day workshop on writing for 
publication run jointly by the Society 
for the Study of Addiction and the 
International Society of Addiction 
Journal Editors. The course is suitable 
for doctoral students, post-doctoral 
research trainees, and junior 
investigators. Tutors are addiction 
journal editors with many years’ 
experience. Participants will get an 
inside look at how editors work and 
how they make decisions about what 
material to publish. Before coming 
to the workshop, participants are 
recommended to read Publishing 
Addiction Science: A Guide for the 
Perplexed. Free downloads from 
www.parint.org and www.isaje.net 
15–16 November 2007 
SSA Annual Symposium 2007: Is 
theory necessary? Theory, policy 
and treatment in addictions: How 
are they related?
Venue: Park Inn Hotel, York, UK
Organised by / Contact: Society for 
the Study of Addiction  
www.addiction-ssa.org
Information: The theme of this year’s 
symposium includes:
Theory, practice and treatment in 
addictions: How are they related?
What are the new developments 
in addictions treatment?
Society lecture: A vision of the 
future of addictions treatment 
■
■
■
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Improving people’s health through research and information
Drugnet Ireland mailing list
If you wish to have your name 
included on the mailing list for 
future issues of Drugnet Ireland, 
please send your contact details 
to:
Alcohol and Drug Research Unit  
Health Research Board 
Knockmaun House  
42–47 Lower Mount Street  
Dublin 2  
Tel: 01 676 1176 ext 127 
Email: adru@hrb.ie
Please indicate whether you 
would also like to be included  
on the mailing list for  
Drugnet Europe.
The Alcohol and Drug Unit 
(ADRU) of the Health Research 
Board is a multi-disciplinary team 
of researchers and information 
specialists who provide objective, 
reliable and comparable 
information on the drug 
situation, its consequences and 
responses in Ireland. The ADRU 
maintains two national drug-
related surveillance systems and 
is the national focal point for the 
European Monitoring Centre for 
Drugs and Drug Addiction. The 
unit also manages the National 
Documentation Centre on Drug 
Use. The ADRU disseminates 
research findings, information 
and news through its quarterly 
newsletter, Drugnet Ireland, and 
other publications. Through 
its activities, the ADRU aims to 
inform policy and practice in 
relation to drug use.
